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Abstract
Basal cell carcinoma (BCC), a keratinocyte cancer, is the most common human neoplasm
worldwide. Although rarely metastatic, BCC is associated with high morbidity rates with
globally rising incidence rates. Accompanying the increase in newly diagnosed cases, the
societal cost for BCC treatment in Canada is also expected to inflate, exceeding over $900
million/year by 2031. Chronic UVB exposure has been identified as the primary carcinogen
that causes activating mutations in the hedgehog signaling pathway. However, there are no
effective preventative methods against BCC, since meta-analyses report sunscreen
application does not reduce BCC in compliant patients. The native high molecular-weight
hyaluronan (HMW-HA) was recently reported to confer tumor resistance to carcinogens
including UVB in naked mole-rats (Heterocephalus glaber). We therefore prepared
phosphatidylethanolamine-linked HMW-HA polymers (HA-PE) for topical application in
UVB-induced, BCC susceptible Ptch+/LacZ/Hr-/- mice. HA-PE formed detectable HA coats
around epidermal and hair follicle keratinocytes, and prevented histologically-detectable
keratinocyte tumor formation, verified by reduced Ptch1 promoter activity indicating
oncogenic hedgehog pathway shutdown. Further evidence of signaling inactivation by HAPE includes strong suppression of the expression of hedgehog pathway gene targets in both
the epidermis and hair follicles. Surprisingly, HA-PE did not prevent UVB/ROS-induced
DNA damage. However, HA-PE promoted quiescence in the hair follicle bulge and
selective apoptosis of K15+ stem cells that are BCC initiating in the Ptch1+/LacZ/Hr-/susceptibility model.

Consistent with this finding, the K15+ stem cells population

decreased from hair follicles between 4-26 weeks of treatment. These results provide
evidence of a novel mechanism for HA-mediated tumor resistance and implicate HA-PE
as a promising BCC prophylactic. This knowledge will also provide a model for probing
the interplay between the microenvironment and oncogenic mutations that permit or
restrain tumor initiation.
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Chapter 1
Introduction
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1.1

Basal cell carcinoma

Basal cell carcinoma (BCCs) are locally aggressive keratinocyte tumors with a recurrence
rate of 50% in 5 years following diagnosis. BCC is the most common form of neoplasm in
adults

1,2,3

, accounting for 70% of all keratinocyte tumors and 90% of all malignant skin

diseases. Chronic exposure to ultraviolet (UV) radiation has been identified as the primary
risk factor for BCC 4. Historically, BCC occurs more frequently in fair-skinned populations
and in males due to increased sun-exposure in workplaces5–9. However, this regional and
sex difference is decreasing due to steady depletion of the protective ozone layer and
enhanced UV exposure in all populations 10–12. Although BCC was originally considered
as a malignancy of the older population (>65 years of age), epidemiological studies report
a dramatic increase in BCC incidence in younger populations during the last decade due to
tanning bed usage

5–7,12–14

. BCC rarely metastasizes, but is locally aggressive and causes

dermal tissue destruction, thus resulting in high morbidity rates 15. Moreover, a history of
non-melanoma skin cancer is associated with increased risk of developing secondary
tumors prone to metastasis, such as breast, prostate and colon cancers16-18. Currently,
societal cost for BCC treatment and related expenses in Canada is approximately $34.6
million (www.iwh.on.ca) and is expected to exceed over $900 million by 2031 (Canadian
Partnership Against Cancer, 2010).
Common treatments of BCC include non-specific surgical removal of tumors, application
of oncogenic pathway inhibitors, and radiotherapy 19,20. However, surgical excisions often
contribute to patient morbidity as they are visibly scarring, while inhibitor treatment is
associated with increased risk of developing secondary low-grade keratinocyte tumors20,21.
Moreover, multiple tumor recurrences are common following surgical excisions and
targeted therapy (up to 7% within 5 years)22–24, contributing to the accumulation of
healthcare cost and deterioration of quality of life. In addition, radiotherapy is commonly
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recommended as a palliative treatment in elderly patients 25, and is associated with higher
cost and recurrence (85% within 3 years) 26,27.

1.1.1

Molecular mechanisms of BCC tumorigenesis

Advancement in the past decade has identified aberrant activation of the sonic hedgehog
signaling as the primary cause of BCC pathogenesis 28,29,30-32. Hedgehog signaling plays a
pivotal role in embryogenesis through orchestrating cell-cell communication of the
epidermis and neural patterning31. During morphogenesis, sonic hedgehog signaling
promotes proliferation, differentiation, and vascularization33, all of which are employed by
tumor cells for growth and metastasis. In post-natal skin, hedgehog signaling promotes
active growth of hair (anagen) and is required for hair follicle-resident multipotent stem
cell proliferation29,34. The pathway is activated when the extracellular ligand sonic
hedgehog (SHH) binds and inhibits the transmembrane receptor Patched1 (PTCH1),
triggering rapid endocytosis of the PTCH-SHH complex33,35. The internalization of PTCH1
releases its suppression of Smoothened (SMO), cumulating in the activation and nuclear
translocation of the GLI family of transcriptional factors (Figure 1). Specifically, GLI2 and
GLI3 accumulate in the nucleus and induce target gene expression in the presence of SHH.
In contrast, GLI1 expression can only be induced by activated GLI2/3 and is dependent on
active sonic hedgehog signaling. Thus, GLI1 is a reliable molecular marker of hedgehog
activation, and its overexpression is characteristic of sporadic BCC29. Other target genes
of the sonic hedgehog pathway include Ptch1, a negative regulator that dampens the signal
transduction of this pathway, and various regulators of cell cycle and apoptosis, such as
Bcl-2 and Ccnd1/2.

29,36

. Since PTCH1 and GLI1 are both regulators and target genes of

hedgehog signaling, they are often used as markers to examine hedgehog signaling
activation37–39.

3

Figure 1: Sonic hedgehog signaling pathway. When the sonic hedgehog ligand (SHH) is
absent, the pathway is inactivated. Tumor-suppressor Patched 1 (PTCH1) inhibits
downstream Smoothened (SMO). However, PTCH1 is inactivated with SHH binding,
allowing SMO to activate the transcriptional factor family GLI to induce target gene
expression. GLI1 expression relies on GLI2/3 activation, therefore its expression level is
often used as an indicator of the overall signaling activity in the sonic hedgehog pathway.
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Pathogenic activation of the sonic hedgehog pathway can occur through sustaining
inactivation mutations in Ptch1, thus abolishing its inhibition of SMO. Genetic studies
report over 90% of sporadic BCC patients sustain Ptch1 mutations, marking Ptch1 as the
most commonly disrupted gene underlying BCC tumorigenesis40,4142. Ptch1 in BCC
patients also contain a high level of UV-signature mutations, suggesting chronic exposure
to environmental UV as the primary risk factor in sporadic BCC43. Mutations in other genes
of the pathway can also lead to BCC pathogenesis and additional neoplasms. For instance,
ligand-independent activating mutations in Smo have been found in 6-21% of sporadic
BCCs

29,42

, while Gli2 overexpression induces BCC tumorigenesis in UVB-exposed

murine models44.
In addition, sonic hedgehog signaling is reported to regulate stem cell lineage maintenance
and cancer stem cell renewal in vivo

45,46

. Overexpression of SHH in post-natal mice

resulted in increased stem cells and atypical proliferation, whereas blockage abolished this
effect46,47. Clinical and molecular evidence suggest BCC carcinogenesis is preceded by
inappropriate hyperactivation of the hedgehog pathway, which normally regulates stem
cell renewal, proliferation, and appropriate hair follicle cycling in post-natal
epidermis33,46,48. Since BCC is a malignancy that originates from epidermal and hair follicle
stem cells, investigating sonic hedgehog signaling in the epidermal stem cell niche is
pivotal to understanding BCC pathogenesis.

1.2

Pathophysiology of BCC
1.2.1

Anatomy of skin

In human, the skin is divided into three layers: the epidermis, dermis, and hypodermis. The
epidermis is further separated into distinct layers based on keratinocyte differentiation. The
basal layer (stratum basale) contains progenitor cells that rapidly proliferate, giving rise to
differentiated keratinocytes in the suprabasal layers (stratum corneum, stratum lucidum,
stratum granulosom, and stratum spinolosum)33. New daughter keratinocytes continuously
migrate upward, which is terminated at the stratum corneum where matured keratinocytes
keratinize and undergo apoptosis (Figure 2).
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Similar to the human integument system, murine epidermis and related appendages are
renewed independently from distinct niches of adult stem cells49,50. Rapid turnover of the
interfollicular epidermis (IFE) is maintained by epidermal stem cells in stratum basale
through mitotic division. In contrast, multipotent cytokeratin-15-expressing (K15) adult
stem cells residing in the bulge region and outer root sheath (ORS) of hair follicles are
responsible for the renewal of the follicles and associated glands51,52. These bulge stem
cells (BuSCs) are slow-cycling and are quiescent until activated by sonic hedgehog
signaling29,34,53,54. Daughter cells from BuSC give rise to transiently-amplifying progenitor
cells, which then rapidly divide symmetrically to renew multiple compartments of the hair
follicle, such as the inner root sheath (IRS) and hair shaft (Figure 2). Transientlyamplifying cells in the hair matrix are defined by their more limited plasticity and
proliferative properties than BuSCs 48. Deprivation of sonic hedgehog signaling results in
BuSC quiescence and interferes with appropriate progression through hair cycle, since
BuSCs proliferation is essential for anagen

55,56

. As observed after administration of

hedgehog inhibitors such as vismodegib and sonidegib, loss of sonic hedgehog signals
prevents BuSC proliferation and telogen-to-anagen transition, resulting in alopecia of
human patients57. Interestingly, neural-derived sonic hedgehog signal also triggers
transient participation of BuSCs in wound healing by stimulating their migration upward
into the epidermis, where they differentiate into multipotent progenitor cells to renew the
IFE 49,54.
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Figure 2: Anatomy of the human skin. A. Hair follicle structure in human. Multipotent
adult stem cells reside within the bulge (green), which is a specialized portion of the outer
root sheath (light orange). Upon stimulation by sonic hedgehog signaling, adult stem cells
proliferate and daughter cells constitute the outer root sheath, eventually differentiating
into transiently-amplifying cells residing within the hair matrix (light green), which flanks
the dermal papillae (yellow). These multipotent progenitors then give rise to the hair shaft
(grey) and the inner root sheath (blue). B. Layers of the epidermis. Interfollicular epidermis
renewal depends on the mitotic division of progenitor cells in stratum basale, with newly
differentiated keratinocytes in the suprabasal layers (stratum spinosum, granulosum,
lucidum, and corneum). The figure is adapted from Blue Histology, University of Western
Australia (http://www.lab.anhb.uwa.edu.au/mb140/).
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1.2.2

Cancer-initiating cells in BCC

Previous in vivo studies report BCC commonly arise from SCs residing within the hair
follicles and the IFE. Aberrant activation of sonic hedgehog signaling causes SCs to enter
a hyperproliferative state and result in neoplastic outgrowths58–61, whereas its inhibition
reduces tumor growth in susceptible mouse models and humans. However, the plasticity
of epithelial SCs adds an additional layer of complexity to the cell origin and epidermal
compartment of BCC initiation. For example, constitutive sonic hedgehog activation
driven by Ptch1 loss produces micronodular BCCs arising from the bulge and ORS regions
in hair follicles. Cell fate tracking of IR-induced BCCs in Ptch+/- mice demonstrate these
keratinocyte tumors originate exclusively from the K15+ BuSCs

58,60,62

, or from their

progeny in follicles44. In contrast, hedgehog dysregulation resulting from overexpression
of downstream components, such as mutant SMO (SmoM2) and GLI2 (GLI2△N), result
in BCC tumors arising from the IFE 59,61. The multipotent K14-expressing adult stem cells
in stratum basale give rise to BCCs associated with the epidermis. The consensus in the
field for this discrepancy is that the loss of tumor-inhibitor PTCH1 and the overexpression
of mutant SMO may produce different biological effects

58,59

. The surprising resistance

against SMO/GLI2-driven tumorigenesis in follicles also suggests the stem cell niche may
act as a key regulator of the tumorigenic potential of BuSCs in BCC initiation 58,59.
Clinical and genetic studies conclude Ptch1 inactivation is the most prominent oncogenic
driver mutation in nodular and micronodular BCC, which are the most prevalent and highrisk histopathological subtype in sporadic BCC patients respectively63,64. These tumors are
characterized by cell nests encircled by scant stroma that is prominently separated from the
surrounding tissue 63–65, consistent with tumors arising from the hair follicles due to Ptch1
loss. In contrast, superficial BCC originates from the IFE in human patients64, consistent
with tumors driven by mutant SMO and GLI2 overexpression in murine models59,61. Since
over 90% of sporadic BCC patients contain Ptch1 inactivating mutation40,43,66, focus has
been placed on the role of PTCH1 inactivation and downstream consequences in the
context of BCC initiation.
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1.2.3

UV radiation and DNA damage

Neoplastic formation induced by chronic UV exposure is widely accepted as the
predominant paradigm in skin carcinogenesis

67–71

. A strong causal link exists between

prolonged UV radiation and BCC, as epidemiological and molecular studies report
approximately 90% of non-melanoma skin cancer are associated with UV exposure 8,43, 72.
UV radiation can introduce inactivating mutations in tumor-suppressors and
inappropriately activate oncogenes, resulting in aberrant proliferation and evasion of
apoptosis in keratinocytes sustaining these mutations. UVB (290 - 320nm) is the most
carcinogenic UV radiation67,69. Prolonged UVB exposure results in direct DNA damages
in the form of cyclobutane pyrimidine dimers (CPD), and is associated with the
accumulation of double-stranded breaks (DSBs) in keratinocytes due to the collapse of
replication forks67,69. The bulky photodimers interfere with the spatial structure of DNA
and proper replication, whereas DSBs possess greater risks of losing of genetic materials
if not repaired effectively. Moreover, evidence suggests chronic UVB exposure augments
skin carcinogenesis through altering immune cell function in the tumor microenvironment,
thus promoting sustained inflammatory response and evasion of immune surveillance69,73–
75

. Constant production of reactive oxygen species (ROS) by recruited immune cells further

contributes to neoplastic initiation in a re-modeled microenvironment76. Since the
epidermis is constantly exposed to environmental UVB, adult stem cells in the stratum
basale and hair follicles pose as vulnerable targets to damage and carcinogenesis.
Next-generation deep sequencing (NGS) demonstrates that BCC contains a high
mutational load compared to metastatic cancer types, such as breast, lung, and ovarian
cancers77–79. Interestingly, this high mutational load does not always affect keratinocyte
tumor initiation, which is defined as the irreversible process of a normal cell in acquiring
the capacity for tumor formation, commonly through oncogenic pathway activation and
subsequent clonal expansion. NGS analyses detected expanded clonal patches of
keratinocytes carrying driver mutations in photo-aged skin without histologicallydetectable tumors79–83. These driver mutations, such as mutational inactivation of TP53, in
UVB-exposed skin occur at a high frequency that is similar to many malignant cancers and
appear to be under strong positive selection, yet the skin remains physiologically normal.
Moreover, in vivo studies of human keratinocytes suggest TP53 mutations conferring to

9

increased proliferative capacity are not sufficient to initiate keratinocyte tumors, as they
were unable to escape the stem cell compartment within the hair follicles to initiate clonal
expansion84. The central role of DNA damage and related repair mechanisms in skin
carcinogenesis is undisputed. However, this combination of experimental and genetic
evidence suggests the existence of an internal barrier, such as tissue architecture or
microenvironmental signal85–87, that serves as an additional barrier in preventing skin
tumorigenesis originating from the follicles.
Currently, there are no effective prophylactics for UVB-induced BCC. Physicians have
long recommended sun-blocks as the primary preventative method against non-melanoma
cancer. However, meta-analyses and longitudinal studies report only a slight reduction in
SCC occurrence, with no significant BCC reduction in compliant patients88-90. Therefore,
development of preventative measures specific for BCC is imperative.

1.3

Naked mole-rats in cancer research

Recent research of cancer-resistant long-lived species yielded potential clues to
preventative medicine against skin carcinogenesis. Naked mole-rats (Heterocephalus
glaber) are long-lived rodents (> 30 years in captivity) that display extraordinary longevity
comparing to mammalian species with similar body mass (i.e: house mouse, 4 years in
captivity). Aside from their exceptional longevity, naked mole-rats also display surprising
resistance against carcinogen-induced tumorigenesis91. Only four cases of cancer have
been reported in these long-lived rodents since captivity, with no reported tumors arising
from keratinocytes92. Seluanov et al. (2009) have attributed this cancer resistance to the
hypersensitivity towards contact inhibition (early contact inhibition, ECI). Naked mole-rat
fibroblasts do not form a confluent monolayer in culture, instead ceasing their proliferative
activities upon few cell-cell contacts. ECI contributes to cancer resistance by promoting
cell cycle arrest through inducing p16INK4A expression93.
The accumulation of epidermal high molecular-weight HA (HMW-HA) has been
established as the extracellular signal that triggers ECI94. HMW-HA accumulation is
attributed to two mechanisms in naked mole-rats: enhanced synthesis (enhanced HAS2
levels) and reduced degradation (low hyaluronidase expression). Importantly, mutant
fibroblast cell lines lacking the ECI phenotype (p16INK4A-/-) still exhibited continuous
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production of HMW-HA while wild-type fibroblasts treated with hyaluronidase displayed
no ECI, therefore placing HA production and signaling upstream of p16INK4A-induced cell
cycle arrest. Moreover, the ECI response mediated by HMW-HA is transmitted through
CD44 binding. Upon blocking CD44 with an antibody, naked mole-rat fibroblasts lost ECI
and reached a higher density in culture. Transformation resistance observed in wild-type
naked mole-rat fibroblasts was lost upon hyaluronidase and anti-CD44 treatments,
producing anchorage-independent growth in culture. Decreased expression of p16 INK4A is
also observed in hyaluronidase-treated fibroblasts, implicating that the ECI phenotype is
modulated by HA/CD44 signaling.
Recently, HMW-HA accumulation has been reported to induce apoptosis in breast cancer
cells in 2D culture95. Overexpression of naked mole-rat HAS2 and exogenous HMW-HA
treatment elevated cytoplasmic cytochrome C expression, caspase activity, ROS
generation and apoptosis in breast cancer cells. This promotion of apoptosis is associated
with inhibition of spheroid growth and tumor formation in vivo, along with downregulated
gene expression involved in proliferation. CD44 expression was significantly upregulated
in 2D, 3D and in vivo models with the elevation of HMW-HA. Taken together, this suggests
the interaction between CD44 and large HA polymers mediates cancer cell apoptosis and
restricts cell cycle progression as a mechanism of cancer resistance in naked mole-rats93–
95

.

1.4

Hyaluronan

Although the central role of oncogenic driver mutations in carcinogenesis is indispensable,
mutations alone appear to be insufficient for tumor initiation. Instead, experimental data
predict the microenvironment can permit or suppress the tumorigenic potential of
mutations87,96,97. The glycosaminoglycan, hyaluronan (HA), is an example of a
microenvironmental agent that regulates tumor initiation and progression

98–100

.

Interestingly, HA of different polymer sizes has distinctive biological functions. High
molecular-weight HA (>500 kDa), such as those observed in naked mole-rats, suppress
proliferation, migration, and other functions that support tumor growth101,102,. In contrast,
low molecular-weight HA (<200 kDa; LMW-HA) promote cell proliferation and invasion,
thus potentiating tumor progression103. HMW-HA also predominates during tissue
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homeostasis, while LMW-HA accumulates during wound repair and tissue remodeling
processes100,103,104. Thus, the bio-information of HA is encoded within its polymer size,
instead of its chemical structure105.
HA is an anionic, linear, non-sulphated glycosaminoglycan (GAGs) composed of repeating
disaccharide units of glucuronic acid and N-acetylglucosamine. It facilitates tissue
hydration via retaining large volumes of water molecules, and participates in regulation of
tissue homeostasis and biomechanical integrity106,107. HA is ubiquitously present but
especially abundant in skin, accounting for approximately 50% of the total body HA108. It
is also present in vitreous of the eye and articular cartilage, where it provides viscoelasticity
and lubrication106,107. As a crucial component in the microenvironment, HA forms a
pericellular matrix that is essential for proper ECM assembly and tissue architecture by
acting as a platform for protein-protein interaction and cell migration106.
Unlike other GAGs, unmodified HA is synthesized on the interior of the plasma membrane.
Membrane-associated hyaluronan synthase (HAS) alternatively add UDP-GluUA and
UDP-GlcNAc substrates to the elongating HA molecule on the inner leaflet of the plasma
membrane. Elongating HA molecule protrudes through the cell membrane and remain
attached via a UDP-anchor, forming a peri-cellular coat following post-translational
modifications. Mammals express three predominate HAS isoforms (HAS1, 2, and 3),
which are encoded on different chromosomes and exhibit distinct enzymatic properties109–
111

. Both HAS1 and HAS2 synthesize large HA polymers (1x106-1x107 Da), while HAS3

preferentially produce smaller sized HA (1x105 Da).
HA facilitates complex physiochemical functions despite its simple chemical structure.
The high molecular-weight native HA polymers (>500 kDa) preferentially produced by
HAS2 contributes to architectural maintenance and hydration of homeostatic adult
tissues101,102,111. However, it can be depolymerized enzymatically by hyaluronidases
(HYAL1-3) into low molecular-weight polymers (<200 kDa) that promote proliferation,
migration, and inflammation

103

. Amongst all hyaluronidases, HYAL2 is often

overexpressed in the peri-tumor stroma, during damage responses and tissue-remodeling
processes104. HYAL2 is an extracellular GPI-anchored protein that targets native HA for
degradation, producing HA fragments of an intermediate size (~20kDa)112,113. The
resulting HA fragments are then endocytosed and delivered to the lysosome, where
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HYAL1,3 further process HA into smaller oligomers (<10kDa, hexasaccharides and
tetrasaccharides). HYAL1, 3 can also be present in the stroma, and are active in a low-pH
microenvironment to facilitate extracellular HYAL-mediated HA degradation103.
Under homeostatic conditions, native HA has a rapid turnover rate of under 24 hours in
skin108. This rapid turnover rate may be required due to the protective functions of HA, as
it acts as a free radical scavenger under inflammatory conditions114–116. Native HA can also
be depolymerized by free radicals, such as ROS produced during inflammation and
exposure to environmental carcinogens (i.e: UV radiation)

117

. Excessive degradation by

ROS and decrease in total skin HA may weaken the protective function of HA, such as
observed after UVB radiation and in BCC118–120. A homeostatic environment is only
maintained when the rate of synthesis keeps pace with degradation. When degradation
exceeds the rate of synthesis, HA fragments accumulate to a significant level, resulting in
altered microenvironmental signaling121–123. LMW-HA polymers interfere with proteinprotein interactions in the pericellular microenvironment, thus jeopardizing the biomatrix
integrity124,125. LMW-HA can also outcompete HMW-HA binding with surface receptors
to alter membrane receptor clustering and downstream intracellular signaling126,127. The
fragments resulting from native HA degradation are a signal for cellular stress and tissue
damage. Their presence has been proposed to initiate responses designed to repair tissue
damage by promoting inflammation and repair. However, cancer cells often upregulate the
production of LMW-HA in an autocrine/paracrine process that promotes stromal
remodeling and tumor progression123,128–130.

1.4.1

HA receptors and signaling

Native HA and LMW-HA bind to various cell surface receptors, including CD44, Receptor
for HA-Mediated Motility (RHAMM), Toll-Like Receptors (TLR), and Human
Hyaluronan Receptor for Endocytosis (HARE)100,131. In keratinocytes, CD44 and
RHAMM are the two major receptors for surface HA126. CD44 is an integral membrane
protein that is involved in cell-matrix adhesion, cell-cell adhesion and migration. It
contains an HA-binding region in the extracellular domain, while its cytoplasmic tail
regulates intracellular protein signaling126. The common standard form of CD44 contains
no extra exons, however the insertion of 10 variable exons (exon 6-15) by alternative
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splicing can generate different isoforms (CD44v1-10) with different physiological
signaling effects and cellular consequences132. CD44v3-10 predominate in keratinocytes,
with CD44v3 as the characteristic isoform in homeostatic skin133–135. HA fragments display
distinct signaling properties comparing to native HA due to their selectivity in receptorbinding 136,137. Studies report LMW-HA/CD44 binding induces ERK1/2 phosphorylation
and triggers pro-inflammatory signaling138,139. In contrast, HMW-HA promotes CD44
clustering at the cell membrane127 but does not trigger ERK1/2 activation136–138. Instead,
HMW-HA facilitates anti-proliferative and anti-inflammatory responses140, such as
competitively inhibiting the NFκB signaling induced by LMW-HA/TLR interaction139,141–
144

.

In contrast to CD44, RHAMM is a multi-functional HA receptor that is not highly
expressed in epidermis under homeostatic conditions. Its expression is typically restricted
to stratum basale, where the proliferative adult stem cells reside, and sparsely scattered
throughout the adjacent layer of stratum spinosum in homeostatic epidermis

145

. Instead,

RHAMM overexpression is associated with tumorigenesis and malignant behaviors 146–150,
specifically in human BCC151. Similar to CD44, RHAMM is capable of interacting with
both HMW- and LMW-HA, but its protein structure dictates HA fragments with very low
molecular-weights as its preferred binding partner

126,146

. RHAMM often co-complexes

with other HA-receptors on the plasma membrane, such as CD44 and TLR, to facilitate
cell migration126. However, the cellular consequences of RHAMM/HA signaling are
highly cell-specific and context-dependent. The subcellular compartmentalization of
RHAMM expression pattern also adds an additional layer of complexity when dissecting
RHAMM-mediated signaling

126,152

. Current literature suggests LMW-HA/RHAMM

interactions have an instructive role in breast cancer initiation and metastasis148,150,153–155,
while RHAMM overexpression is found in nodular BCC of patients151. However, the
precise molecular effects of HA/RHAMM interaction in BCC remains elusive.

1.4.2

The hyaluronome in carcinogenesis

HA synthases, hyaluronidases, and HA receptors on the plasma membrane such as CD44
and RHAMM constitute a complex “hyaluronome”, which regulates HA functions and
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metabolism. Sustained HA fragmentation is an endogenous danger signal that participates
in various tissue remodeling processes such as embryogenesis, wound repair, and
tumorigenesis116,131,156. Specifically, LMW-HA accumulation potentiates the invasive
tumor phenotype121,156,157 by upregulating hyaluronidase expression and activities. HYAL1
overexpression correlates with bladder and prostate cancer progression158–161,162, while
HYAL2 upregulation is associated with malignant cutaneous melanoma and mammary
gland tumor behavior 163,164. Tumor cells remodel the microenvironment via upregulating
HAS2, HYAL1 or HYAL2, thus promoting excessive HA synthesis and sustained
degradation to potentiate invasion and metastasis 165–167. Clinical and experimental studies
also report elevated LMW-HA polymers promote lymph node metastasis of breast and
melanoma cells 124,156, while correlating with poor patient prognosis156. Moreover, LMWHA is a potent promoter of inflammation, which is a key aspect of the remodeled tumor
microenvironment. Fragmented HA facilitates macrophage recruitment and differentiation
into the tumorigenic M2 phenotype via regulating Th1/Th2 cytokine balance, thus
enhancing local ROS production and further contribute to LMW-HA production168.
Fragmented HA also induces the phosphorylation and activation of the pro-inflammatory
NFκB126,142, which is critical in establishing a tumor-permissive microenvironment for skin
carcinogenesis75.
In contrast to LMW-HA, native HA restricts cell cycle progression98,127. HAS2
overexpression and hyaluronidase knockdown reduce tumor growth rate in murine
astrocytoma cell lines169. Similarly, administration of HMW-HA post-chemotherapy
significantly inhibits tumor regrowth in colon carcinoma xenograft mice170. Native HA has
also been reported to reduce the migratory capacity of aggressive cancer cell lines via
strengthening the cell-cell junctions, thus decreasing the ECM permeability and preventing
cancerous outgrowths 125. Moreover, native HA is a well-established microenvironmental
anti-oxidant and ROS scavenger114–116. Recent findings report reduced γ-H2AX foci
formation,

a

biomarker

for

DSB

sites,

corresponding

to

HMW-HA

accumulation114,171,172,173, thus suggesting HA-mediated genoprotection as a possible
cancer-prevention mechanism. HMW-HA/CD44 interaction is also a well-established
inhibitor of inflammation through its regulation of the canonical NFκB signaling121,140.
Mediated by p65/p50 heterodimers, NFκB is a pro-inflammatory pathway that promotes
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the expression of SHH174,175, the activating ligand in sonic hedgehog signaling, which
drives BCC initiation.
Taken together, the current literature suggests that the continuous depolymerization of HA
enhances the oncogenic potential of the microenvironment. In contrast, HMW-HA
accumulation limits tumorigenicity by restricting proliferation, invasion, and provides
genoprotection. However, further conceptual advancement is required to understand the
distinct size-dependent biological effects of HA in the context of tumorigenesis, and to
fully harvest the therapeutic potential of HA as a microenvironmental regulator.

1.4.3

Phosphatidylethanolamine-linked high
molecular-weight hyaluronan

Although the accumulation of native HA is associated with offering protection against
oncogenic assaults and tumorigenesis in mice157,176, human140,171, and naked mole-rats93,95,
the role of HMW-HA has not yet been described in keratinocyte tumors. Conceptual
advancements in the past decade have identified the primarily oncogenic driver and the
cancer-initiating cells in the epidermal microenvironment, and established wellcharacterized mouse models to study BCC. Thus, this keratinocyte cancer is an ideal
disease model to interrogate the effects of microenvironmental agents on regulating the
tumorigenic potential of cancer-initiating cells. Exogenous applications of HMW-HA have
been reported to reduce inflammation in vitro 177 and restore skin homeostasis in aged mice
by promoting epidermal barrier function178, all are critical to suppressing tumorigenesis.
Although promising, current delivery methods failed to reliably and efficiently distribute
and retain HA with molecular weights greater than 50kDa in the epidermis and dermis179–
181

. This failure is likely due to the large molecular weight and high hydrophilicity of native

HA, resulting in poor absorption across the hydrophobic stratum corneum182. Rapid
degradation of exogenous HA formulation by cells and the dependency of receptor
expression for pericellular coat formation further contribute to the failure of sustained
HMW-HA delivery into the epidermis182.
To

address

these

issues,

native

hyaluronan

polymers

were

linked

to

phosphatidylethanolamine (HA-PE) and incorporated into a topical formulation (patent
number: US20130059769A1; E. Turley, WorlDiscoveries) 183. To further investigate the
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role of HA in offering BCC protection, HA-PE was applied onto the dorsal skin of UVBexposed Ptch+/LacZ/Hr-/- mice, which are susceptible to UVB-induced keratinocyte
tumors184,185. HA-PE allowed the formation of sustained HA-coats on epidermal
keratinocytes and dermal fibroblasts upon topical application

183

. Previously, we

demonstrated that the formation of HA-coat was independent of major HA receptors on the
plasma membrane, CD44, but instead was augmented by its linkage with
phosphatidylethanolamine183. The HA-coat sustained on cell membrane 72 hours postadministration, which exceeds the normal native hyaluronan half-life in the epidermis183.
This accumulation of epidermal HA was associated with no histologically-detectable
keratinocyte tumor formation in BCC-susceptible mice, while control groups
spontaneously developed keratinocyte tumors after UVB treatment.

1.5

Animal models in BCC research

An appropriate animal model should permit the analysis of the molecular pathogenesis
underlying tumor initiation and allow for the assessment of preventative therapies. Key
players in the sonic hedgehog pathway are ideal to study BCC in murine models since it is
the primary oncogenic driver pathway in skin carcinogenesis. Mouse models carrying a
heterozygous Ptch1 knockout, overexpression of SHH, mutant active SMO, and GLI2 have
been well-characterized as appropriate models to study sporadic development of BCC58–62.
Since inactivating mutations of PTCH1 is the most common genetic alteration in human
BCCs and homozygous loss of Ptch1 is embryonically lethal, Ptch+/- mutants are the most
appropriate model to study human BCC. A common Ptch+/- model is established by the
replacing exon 1 and 2 of the Ptch1 allele with a LacZ gene, thus introducing an
inactivating mutation

186

. The Ptch1+/LacZ genotype increases susceptibility of sporadic

BCC development upon chronic UV exposure (up to 32 weeks) in mice, and allows the
protein product, β-galactosidase (β-gal), to be used as a reporter for Ptch1 expression 186.
Mice carrying homozygous mutational inactivation of Hairless (Hr-/-), a transcriptional corepressor essential for hair cycling and growth187–189, is another model commonly used in
dermatologic research concerning keratinocyte tumorigenesis186,190. More commonly used
to study SCC initiation and progression, Hr-/- mice exhibits disrupted hair follicles and the
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hairless phenotype (alopecia) after one round of normal hair cycling in newborn
litters189,191. Biallelic Hr loss accelerates the keratinocyte tumor initiation process
comparing to haired littermates, without altering the expression of sonic hedgehog and
BCC-related oncogenic driver pathway components in mice186. Although the morphology
of hair follicles is disrupted, the cell compositions and functions in the hair follicles are not
altered191. Hairless phenotype also allowed us to directly apply topical HA-PE cream to
directly assess the protective effects of HMW-HA. At the molecular and histological levels,
UV-induced skin neoplasms in Hr-/- models closely resemble tumors in human
patients186,190, therefore representing an appropriate model to examine keratinocyte tumors
in mice.

1.6

Hypothesis and objectives

Since both carcinogens and initiating driver pathway mutations of BCC are wellestablished in human and mice, we decided to interrogate the cancer resistant ability of
HMW-HA in the context of BCC initiation. Previously, histopathological analyses reported
the complete lack of keratinocyte neoplasm occurrence after HA-PE treatment in
chronically UVB-exposed Ptch+/LacZ/Hr-/- mice. Here, I aim to identify the mechanisms of
HA-mediated resistance against keratinocyte tumorigenesis. HA-PE treatment is
hypothesized to offer resistance against BCC initiation through inhibiting the oncogenic
driver, sonic hedgehog signaling pathway, in the epidermis and hair follicles of susceptible
mice. Therefore, the following objectives were proposed to test this hypothesis.
Objective 1: Verify HA-PE mediated inhibition of BCC tumor initiation by assessing
sonic hedgehog signaling in Ptch+/LacZ/Hr-/- mice.
We chose to investigate the sonic hedgehog pathway to assess tumor initiation, since its
aberrant signaling is essential for BCC pathogenesis in human and mouse models29,32. The
overexpression of PTCH1 and GLI1 are well-established molecular markers for signaling
activities since they are both target genes and regulator of this oncogenic pathway.
Moreover, the insertion of a promoterless E. coli LacZ gene into Ptch1 allows the usage of
bacterial β-gal to measure Ptch1 promoter activity. LacZ insertion also introduces a
heterozygous loss-of-function mutation in Ptch1, thus mimicking the genotype of sporadic

18

BCC patients40,43,66. Therefore, we used β-gal and GLI1 expression as a measurement of
sonic hedgehog signaling and BCC initiation in Ptch+/LacZ/Hr-/- mice.
Objective 2: Determine the cellular consequences of HA-PE application in
Ptch+/LacZ/Hr-/- mice.
To investigate the mechanisms that are responsible for the suppressive effects against
UVB-induced BCC tumorigenesis, the cellular effects of HA-PE application on epidermal
keratinocytes and hair follicle cells were examined. HMW-HA was reported to act as a
genoprotective agent by acting as a free-radical scavenger114–116, thus the DNA damage in
epidermis and hair follicles of UVB-exposed mice was assessed. Target genes of sonic
hedgehog signaling (cyclin D1, BCL2) and associated cellular consequences (cell cycle
progression and apoptosis) were also investigated in transgenic mice.
Aim 1: Assess if HA-PE application protected keratinocytes from UVB- and ROS-induced
DNA damage.
Aim 2: Examine the effects of HA-PE on cell cycle progression and apoptosis in the
epidermis of UVB-exposed mice.
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Chapter 2

2

Materials and methods
2.1

Animal studies

Experiments were approved by and compliant with the standard operating procedures of
the Animal Use Subcommittee at the University of Western Ontario (2009-060). All animal
experiments were conducted by Katelyn Cousteils, with detailed breeding schemas and
conditions reported previously192. Briefly, female Hr-/-/SKH-1 mice (Strain 477, Charles
River Laboratories, Wilmington, MA, USA) were crossed with Ptch+/LacZ/C57BL/6 male,
haired mice (Stock number 003091, Jackson Laboratory, Bar Harbor, ME, USA). F1 litters
between 14 to 21 days of age were genotyped for Ptch+/- heterozygosity. F1 Ptch+/-/Hr+/male mice were crossed with F1 Ptch+/-/Hr+/- female mice, and F2 Ptch+/-/Hr-/- mice were
utilized for the study.
Ptch+/-/Hr-/- mice were separated into four experimental groups: no UVB control (No UVB,
n= 5), UVB-only control (UVB, n=7), UVB with vehicle cream control (UVB + vehicle,
n=10), and UVB with HA-PE cream (UVB+HA-PE, n=10). An UV-irradiation unit
(Daavlin Co., Bryan, OH, USA) equipped with an electronic UV-dosage controller186 was
used to administer UV radiation. Litters between 6 to 7 weeks of age were selected and
exposed to UV irradiation, which was composed of UVA of 315-400 nm, accounting for
20% of total energy; and UVB of 290-315 nm, accounting for 80% of total energy. Subjects
were irradiated for 4 weeks and 26 weeks to study the acute and chronic effects of HA-PE
on UVB-induced BCC, respectively. Litters received 180 mJ/cm2 of UVB irradiation twice
per week (Thursdays and Fridays) for 30 to 45 seconds, while vehicle or HA-PE cream
was applied prior to UVB-irradiation, once daily for five days each week (Monday to
Friday).
Lesions and skin abnormalities were measured using digital calipers (500-170-30, Aurora,
IL, USA), excised using 8-mm punch biopsy from the dorsal back, and processed to be
paraffin-embedded for histological analyses. Lesion-adjacent phenotypically-normal skin
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was also excised using an 8-mm punch biopsy, frozen using 70% ethanol and dry ice and
stored at -80℃.
Histopathology analysis of skin abnormalities was conducted at the Centre for
Phenogenomics (Toronto, ON, CA) using paraffin-embedded slides stained with H&E.
Neoplasia was identified by histological features characteristic of BCC (large nuclei, scant
cytoplasm, mitotic features), cell morphology, and clonal expansion.

2.2

Immunohistochemistry

Immunohistochemistry of paraffin-embedded tissue was conducted as previously
described193. Briefly, sections were de-paraffinized through two passages of xylene for 15
minutes each wash and rehydrated through a descending ethanol series (100%, 95%, 70%)
for 10 minutes each change. Slides were washed in buffer (Table 1) and one change of
dH2O for 5 minutes each. Antigen retrieval was performed using 10mM sodium citrate
buffer (pH 6.0) in a standard microwave. Specimen were washed in the two changes of the
appropriate buffer for 5 minutes each, and endogenous peroxidase activity was inhibited
by incubating slides in 3% H2O2 for 20 minutes. Non-specific antibody binding was
blocked by incubating slides in 3% bovine serum albumin (BSA) at room temperature for
1 hour. Diluted primary antibody was added to each slide and incubated at 4℃ overnight
in humidifying chambers, with non-immune anti-mouse immunoglobulin (IgG) incubated
on the negative control (Table 1). Following two washes in the appropriate buffer solution,
the slides were incubated with 1:100 biotinylated goat anti-rabbit secondary antibody
(catalog number: E0432, Agilent Technologies, CA, USA) diluted in phosphate buffer
saline (PBS: 137 mM NaCl, 12 mM phosphate, 2.7 mM KCl, pH 7.4) or Tris-buffer saline
(TBS: 50 mM Tris-Cl, pH 7.5, 150 mM NaCl) at room temperature (approximately 25℃)
for 2 hours in humidifying chambers. Streptavidin-conjugated horseradish-peroxidase
(catalog number: ab7403, AbCam, MA, USA) was diluted in 1xPBS or TBS to 1:1000fold and added onto each slide for 30 minutes at room temperature, followed by incubation
with diaminobenzidine substrate (DAB, catalog number: K3467, Agilent Technologies,
CA, USA). Counterstaining was carried out using hematoxylin diluted 1:10-fold in ddH2O
(10143-606, VWR, PA, USA). Sections were dehydrated by passaging through the ethanol
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series (70%, 95%, 100%) and two changes of xylene. All slides were mounted using
Cytoseal-60 (catalog number: 8310-16, ThermoFisher Scientific, MA, USA), and dried at
room temperature.

2.2.1

Image analysis

All sections were scanned using Aperio ScanScope (Leica Biosystems, Wetzlar, Germany)
and analyzed using ImageJ or QuPath. All quantifications were conducted on the epidermis
of animal sections, and keratinocytes within the field of view were quantified according to
their epidermal compartmentalization (suprabasal layer, stratum basale, and hair follicles).
For intensity quantification, the DAB channel in each image was separated from the
hematoxylin channel using the “Colour deconvolution” algorithm, and measured using the
“Pixel measurement” algorithms in ImageJ. DAB-stained brown pixels in slides from all
experimental groups were compared to the negative control, which was used as the
threshold. Semi-automatic positive cell counts of all slides were conducted using the
“Positive cell detection” algorithm from QuPath (v0.1.9) as previously described194, and
all algorithm-generated data were verified by manual counting.

2.2.2

Vertical lineage tracing

Vertical lineage tracing was conducted on γ-H2AX stained paraffin-embedded tissues.
Daughter cells proliferating from progenitor cells in the stratum basale layer were
identified, and the number of γ-H2AX positive daughter cells originating from the same
progenitor cell was quantified through manual cell counting using ImageJ. All suprabasal
keratinocytes and basal progenitor cells in images were quantified.

2.3

Immunofluorescence and image analysis

Immunofluorescence of paraffin-embedded tissue sections was conducted identically to the
protocol for immunohistochemistry (section 2.2 and 2.2.1) described above, with the
quenching of endogenous peroxidase omitted. After secondary antibody incubation using
either Alexa 488-conjugated mouse anti-rabbit IgG (catalog number: A32731, Invitrogen,
MA, USA) at 1:200-fold dilution or Alexa 555-conjugated mouse anti-mouse IgG (catalog
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number: A32727, Invitrogen, MA, USA) at a 1:200-fold dilution, slides were washed in
the appropriate buffer solution (Table 1). Sections were then mounted using DAPIcontaining ProLong Gold anti-fade mounting reagent (catalog number: P36931,
ThermoFisher Scientific, MA, USA).
All tissue sections were imaged using IX81 Olympus confocal microscope equipped with
FV10-ASW 4.2 software at 20x or 40x magnifications. Images were saved in tiff format
and quantified using ImageJ or QuPath as described above. Keratinocytes within the field
of view were quantified according to their epidermal compartmentalization (suprabasal
layer, stratum basale, and hair follicles). To quantify the intensity of antibody
immunoreactivity, DAPI, FITC and TexasRed channels were first separated in ImageJ
using the “Split channel” algorithm, and threshold against the negative control. Epidermal
compartments in each field of view were selected manually, and the “Pixel measurement”
algorithm was used to detect intensity. Similarly, individual colour channels were separated
in QuPath and the “Positive cell detection” algorithm was used to detect keratinocytes
positive for antibody staining as previously described194, and all algorithm-generated
counts were verified manually.
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Table 1: Antibodies and buffers used in immunohistochemistry and
immunofluorescence of paraffin-embedded tissue sections.
Primary antibody
β-galactosidase

Catalog number
A11132, Life Technologies

Dilution

Wash

Antigen

buffer

retrieval buffer

1:200

1xPBS

Corporation, CA, USA
GLI1

ab151796, Abcam, MA, USA

1:900

1xTBS

CD44

553130, BD Biosciences, ON, CA

1:200

1xPBS

RHAMM

ab124729, Abcam, MA, USA

1:50

1xPBS

Phospho-histone

9718, Cell Signalling Technology,

1:150

1xTBS

H2AX (Ser139)

MA, USA

Bcl-2

sc-492, Santa Cruz Biotechnology

1:300

1xPBS

Cyclin D1

ab16663, Abcam, MA, USA

1:100

1xTBS

Ki67

ab16667, Abcam, MA, USA

1:100

1xPBS

NFκB-p50

sc-114, Santa Cruz, Biotechnology

1:100

1xTBS

NFκB-p65

Sc-8008, Santa Crux Biotechnology

1:100

1xTBS

SMA

ab124964, Abcam, MA, USA

1:100

1xPBS

Cleaved caspase 3

9664, Cell Signalling Technology,

1:50

1xTBS

(Asp175)

MA, USA

Cytokeratin-15

ab80522, Abcam, MA, USA

10 mM Sodium
citrate, pH 6.0

10 mM Sodium
citrate, 0.05%

1:100

1xTBS

Tween-20, pH
6.0
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2.4

Detection of HA in tissue sections and analysis

HA detection in paraffin-embedded tissue sections was conducted similarly to the protocol
for immunohistochemistry described above, with modifications stated below. Following
de-paraffinization of slides, the antigen retrieval step was omitted. The primary antibody
was replaced by an HA-binding biotinylated protein (catalog number: K-1203, Echelon
Biosciences, UT, USA), and incubated at 37℃ for 1 hour. Negative control was established
by replacing the HA-binding biotylinated protein with 3% bovine serum albumin diluted
in PBS. Slides were incubated in 3% H2O2 for 15 minutes at room temperature and
incubated with HRP/streptavidin diluted to 1:1000-fold in 1xPBS. DAB reagents were
added onto each slide for 20 minutes at room temperature, and counterstained with Harris’
Hematoxylin (catalog number: 10143-606, VWR, PA, USA) at 1:10-fold diluted with
dH2O. All slides were washed in 1xPBS for 10 minutes between each step. Sections were
dehydrated by passage through the ethanol series and xylene in reverse, and mounted in
Cytoseal-60. Quantification of HA staining was carried identically to the protocols for
immunohistochemistry quantification described above.

2.5

RT-qPCR
2.5.1

Total RNA extraction from tissue

RNA extraction from tissue was performed via standard trizol/chloroform extraction
protocol. All equipment was cleaned with 70% ethanol and RNase-away solution (catalog
number: 10328-011, Invitrogen, MA, USA). Briefly, approximately 1 gram of frozen skin
biopsy and 500 μL of trizol (catalog number: 15596018, Life Technologies Corporation,
CA, USA) were added into a micro-centrifuge tube, and homogenized using a hand-held
Dounce homogenizer. Fresh 500uL of trizol were added to samples once they are
adequately homogenized, followed by mixing by inversion and incubated at -20℃ for 5
minutes. 200 μL of chloroform (catalog number: 423555000, Acros Organics, NJ, USA)
was added to samples, vortexed for 10 seconds and incubated at room temperature for 3
minutes. Samples were centrifuged at 4℃ for 15 minutes at 12,000 rpm, with the top
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aqueous layer transferred into new tubes. Ice-cold isopropanol (500 μL) was added to
samples and stored at -20℃ overnight. Samples were centrifuged at 4℃ for 30 minutes at
12,000 rpm, and supernatants were discarded with the pellets washed in ice-cold 70%
ethanol. Samples were centrifuged at 4℃ for 10 minutes at 7,500 rpm, and the supernatants
were aspirated. Pellets were air-dried and resuspended in 20 μL of nuclease-free ddH2O,
with the RNA concentration measured via NanoDrop One/OneC (ThermoFisher Scientific,
MA, USA). Samples with an A260/280 > 1.9 and A260/230 > 1.7 were used for further
experiments, and stored at -80℃ until further assays.

2.5.2

In vitro reverse transcription

Complementary DNA (cDNA) was synthesized using SuperScript IV VILO Master Mix
kit (catalog number: 11756050, Invitrogen, MA, USA). 4 μL of SuperScript IV VILO
master mix solution was incubated with 1 μg of RNA template and nuclease-free water for
a final reaction volume of 20 μL. Samples were gently mixed at incubated at 25℃ for 10
minutes to allow primer annealing, followed by incubation at 50℃ for 1 hour to allow
elongation. Samples were then heated to 85℃ for 5 minutes to inactivate reverse
transcriptase, briefly centrifuged and stored at -20℃ until further assays were performed.

2.5.3

PCR reactions and analysis

RT-PCR was performed to analyze CD44 expression in transgenic mice. Each PCR
reaction consisted of 20 ng of cDNA template, 0.5 μL of 10 μM forward and reverse
primers (Table 2), 0.5 μL of GC enhancer, 10 μL of AmpliTaq 360 master mix, and
nuclease-free ddH2O to reach a total volume of 25 μL. PCR reactions were carried out at
95℃ for 10 minutes, 94℃ for 30 seconds, 55℃ for 30 seconds, 72℃ for 30 seconds for
40 cycles, and a final elongation step at 72℃ for 7 minutes using DNA Engine Tetrad 2
Thermocycler (Bio Rad, CA, USA). All target gene expression was compared with the
house control gene GAPDH on a 1% agarose gel containing ethidium bromide, and imaged
using ChemiDocTM XRS+ System (Bio Rad, CA, USA).
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2.5.4

Real-time PCR reactions and analysis

RT-qPCR was performed to analyze the mRNA expression of Hyal2, Hyal3, Hmmr, Shh,
Cccnb1, Cdk4, and Gapdh in transgenic mice. Each PCR reaction consisted of 20 ng of
cDNA template, 0.5uL of 10uM forward and reverse primers (Table 2), 10 μL of SYBR
Green PCR Master Mix (catalog number: 4309155, Thermofisher Scientific, MA, USA),
and nuclease-free ddH2O to reach a total volume of 20 μL. PCR reactions were carried out
on a 96-well plate at 95℃ for 3 minutes, 60℃ for 10 seconds, and 72℃ for 30 seconds for
40 cycles using Stratagene Mx3000P system (Agilent Technologies, Santa Clara, CA). Ct
values were exported from the thermocycler and analyzed using excel according to the 2△CT

method.
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Table 2: Primers used in RT-qPCR and RT-PCR.
Gene

Forward primer

Reverse primer

Hyal2

GCAGGACTAGGTCCCATCATC

TTCCATGCTACCACAAAGGGT

Hyal2

TCTGTGGTATGGAATGTACCCT

TGCACACCAAAATGGGCCTTA

CD44s

GCCTACTGGAGATCAGGATG

GATCCATGAGTCACAGTGCG

CD44v3

GCCTACTGGAGATCAGGATG

TCATTTTCCTCATTTGGCTCCC

CD44v4

GCCTACTGGAGATCAGGATG

TCTGGGTTTGAATGGTTTGGC

CD44v8

ACAACCCTTCAGCCTACTGC

GATCCATGAGTCACAGTGCG

CD44 v10

CCCAGTGACCCCTGCTAAAA

GATCCATGAGTCACAGTGCG

Hmmr

CCTTGCTTGCTTCGGCTAAAA

AGCAAAGCTCAATGCAGCAG

Shh

GGCAGATATGAAGGGAAGAT

ACTGCTCGACCCTCATAGTG

Ccnb1

AGCAAATATGAGGAGATGTACC

CGACTTTAGATGCTCTACGGA

Cdk4

AACTGATCGGGACATCAAGG

CAGGCCGCTTAGAAACTGAC

Gapdh

TGAGGCCGGTGCT
GAGTATGTCG

CCACAGTCTTCTG
GGTGGCAGTG
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Enzyme-linked immunosorbent assays

2.6

2.6.1

DNA extraction from tissue

Approximately 1 gram of frozen tissue sample was incubated in lysis buffer (1M Tris, 0.5M
EDTA, 10% SDS, 5M NaCl, pH 8.0) and 20 mg/mL proteinase K (Roche, Mannheim,
Germany) overnight at 55℃ with constant agitation. Samples were centrifuged at 200xg
for 10 minutes at room temperature, and the supernatants in each sample were transferred
into new tubes. 100 μL of Protein precipitation solution (catalog number: A975A, Promega
Corporation, WI, USA) was added to samples and centrifuged at 14,000xg for 10 minutes.
Supernatants were briefly chilled on ice followed by centrifugation at 14,000xg for 5
minutes, with pellets discarded. Immediately after, ice-cold isopropanol (500 μL) was
added to supernatants, mixed by inversion five times and incubated at -20℃ for 30 minutes.
All samples were centrifuged at 14,000xg for 15 minutes, and pellets were washed with
ice-cold 70% ethanol. After, samples were centrifuged at 14,000xg for 10 minutes again
and washed pellets using ice-cold 70%. Resulting pellets were air-dried at room
temperature and suspended in 20 μL of ddH2O. Sample concentration were measured using
NanoDrop One/OneC (ThermoFisher Scientific, MA, USA), and stored in -20℃ until
further use. Only samples with an A260/280 ratio between 1.8 to 1.9 were used in future
experiments.

2.6.2

8-oxo-2’-deoxyguanosine ELISA

Nuclear ROS-adducts 8-oxo-2’-deoxyguanosine (8-oxo-dG) were detected using a
commercially available ELISA kit (catalog number: 4380-096-K, Trevigen, MD, USA).
DNA was extracted from frozen tissue as described in section 2.5.1. Samples were diluted
in nuclease-free ddH2O to 200 μg/mL, and 100X cations (catalog number: 4380-096-05)
was added for a final 1X concentration. 0.8 μL of DNase I (catalog number: 4380-096-06,
5 U/uL) and alkaline phosphatase (catalog number: 4386-096-07) were added to each
sample and incubated at 37℃ for 1 hour separately. Digested samples were aliquoted and
stored at -20℃ until assayed. 8-oxo-dG standards (catalog number: 4380-096-01, 20 μM)
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were serially diluted with assay diluent (catalog number: 4380-096-02) to construct a
standard curve (200 nM, 100 nM, 50 nM, 25 nM, 12.5 nM, 6.25 nM, and 3.13 nM). 25 μL
of standards, blank and DNA samples were pipetted in triplicates into a 96-well plate precoated with 8-oxo-dG, with 25 μL of anti-8-OHdG monoclonal antibody (catalog number:
4380-096-03, diluted 1:250-fold in assay diluent) added to each well. The plate was
covered with a film sealer and incubated for 1 hour at 25℃. All wells were washed with 4
changes of 1xPBST (137 mM NaCl, 12 mM phosphate, 2.7 mM KCl, pH 7.4, 0.1% Tween20) for 30 seconds, with excess liquid aspirated. Goat-anti-mouse IgG-HRP conjugate
(catalog number: 4380-096-04, diluted 1:500-fold in assay diluent) was added to all wells,
and incubated at 25℃ for 1 hour. The plate was then washed with 4 changes of 1xPBST
with excessive liquid aspirated. 50 μL of room-temperature TACS-Sapphire colorimetric
substrate (catalog number: 4822-096-08) was added to all wells, and incubated for 15
minutes at 25℃ in the dark. The reactions were stopped by adding 50 μL of 5% phosphoric
acid to all wells, and absorbance was read immediately at 450 nm.
The average absorbance for all standards, samples and blanks were calculated, with the
blank average subtracted from standard and sample averages to determine relative
absorbance. The log of 8-oxo-dG standard concentration (ng/mL) was plotted against the
relative absorbance to derive a standard curve, and 8-oxo-dG concentration in samples was
calculated and interpolated from the standard curve.

2.6.3

Cyclobutane pyrimidine dimer ELISA

Protocol was carried at as described by the manufacturer (catalog number: STA-322, Cell
Biolabs). Briefly, genomic DNA (gDNA) was extracted from tissue samples as described
in section 2.7.1, and incubated at 95℃ for 10 minutes to denature double-stranded DNA
(dsDNA) into single-stranded DNA (ssDNA). Samples were briefly chilled on ice, and
diluted to 4 μg/mL in ice-cold 1xTE buffer (10 mM Tris, pH 8.0, 1mM EDTA). Similarly,
CPD-DNA standards and reduced DNA provided in the commercial kit were denatured
into ssDNA via incubation at 95℃ for 10 minutes. Standards were serially diluted to create
a standard curve (0, 1.56, 3.13, 6.25, 12.5, 25, 50, 100 ng/mL) in ice-cold TE buffer.
Samples and CPD-DNA standards were added to a 96-well plate, with an equal volume of
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DNA binding solution added to each well and mixed thoroughly via pipetting. The plate
was incubated at room temperature overnight with constant agitation. Solutions were
aspirated and wells were washed twice with 1xPBS, with excess fluid removed by blotting.
Assay diluent was added to each well to block non-specific binding at room temperature
for 1 hour. After assay diluent was removed from well, anti-CPD antibody (catalog number:
232202, Cell Biolabs) were diluted 1:1000 in 1xTE buffer and added to each well and
incubated at room temperature for 1 hour with constant agitation. All wells were washed
five times with wash buffer and blotted to remove excess fluid, followed by incubation
with secondary antibody-HRP conjugate (diluted 1:1000 in 1xTE buffer, catalog
number:10902, Cell Biolabs) at room temperature for 1 hour on an orbital shaker. Plate
was washed five times in wash buffer and excess fluid was removed. Substrate solution
warmed to room temperature was incubated in each well for 20 minutes, stop solution was
added to each well to stop the enzyme reaction. Absorbance of all wells was read using a
microplate reader at 450 nm immediately after stop solution addition. Reduced DNA
standard was used as an absorbance blank, and all DNA samples were assayed in triplicates.
The average absorbance for all standards, samples and blanks was calculated, with the
blank average subtracted from standard and sample averages to determine relative
absorbance. The CPD-DNA standard concentration (ng/mL) was plotted against the
relative absorbance at OD450nm to derive a standard curve. The CPD concentration in
extracted DNA was calculated and interpolated using the standard curve.

2.7

Terminal deoxynucleotidyl transferase dUTP nick

end labeling (TUNEL) assay
Detection of apoptosis was carried out using ApopTag Fluorescein In Situ Apoptosis
Detection Kit (S7110, EMD Millipore, MA, USA) following the protocol provided by the
manufacturer. Briefly, slides were deparaffinized by passage through two changes of
xylene (10 minutes each wash) and a descending series of ethanol (100%, 95%, and 70%
for 5 minutes each wash), followed by one change of 1xPBS for 5 minutes. Slides were
incubated in freshly diluted proteinase K (20 μg/mL) for 15 minutes at room temperature,
and washed in 2 changes of 1xPBS for 2 minutes each wash. Equilibration buffer was
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added to each specimen and incubated at room temperature for 30 minutes. Immediately
afterward, 55uL of terminal deoxynucleotidyl transferase (catalog number: 90418, EMD
Millipore, MA, USA) and reaction buffer (catalog number: 90417, EMD Millipore, MA,
USA) mixture in 1:3 ratio was added to slides, and stored in humidified chambers at 37℃
for 1 hour. Negative and positive controls were established by omitting the reaction buffer
in the mixture and treatment with DNase I (catalog number: 4380-096-06, 5U/uL, Trevigan,
MD, USA) at 37℃ for 1 hour, respectively. Reaction was stopped by incubating in Stop
Buffer (catalog number: 90419, EMD Millipore, MA, USA) at room temperature for 10
minutes, followed by 3 washes in 1xPBS for 1 minute each wash. Room-temperature
mixture containing anti-digoxigenin conjugate (catalog number: 90426, EMD Millipore,
MA, USA) and blocking solution (catalog number: 90425, EMD Millipore, MA, USA)
was added to each specimen, and incubated at room temperature for 30 minutes in the dark.
All slides were washed in 4 changes of 1xPBS for 2 minutes each wash, and counterstained
with DAPI-containing ProLong Gold anti-fade mounting reagent. All specimens were
stored at -20℃ in the dark.
Images were captured on IX81 Olympus confocal microscope using the negative control
as the minimal threshold for laser settings. All images were analyzed using ImageJ to
manually count TUNEL-positive cells in each image (approximately 1000 cells per field),
with the interfollicular epidermis and hair follicles quantified separately.

2.8

Hyaluronidase activity ELISA-like assay

Detection of hyaluronidase activity in whole skin samples was conducted as described
previously195,196. Briefly, 3 grams of tissue was suspended in ice-cold homogenization
buffer (5 mM HEPES, pH 7.2; 1 mM benzamidine-HCl) and homogenized using a Dounce
homogenizer (Ika Works Inc, Wilmington, NC). Lysate was centrifuged at 10,000xg for
30 minutes, with total protein concentration measured through BCA assay and compared
to a BSA standard curve.
A 96-well plate was coated with high molecular-weight human umbilical hyaluronan (200
μg/mL, H1876, Sigma-Aldrich, MO, USA) diluted in 0.1M sodium bicarbonate solution
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(pH 9.2) overnight at 4℃. HA-coated wells were washed three times in 1xPBST. Tissue
samples were diluted in reaction buffer (0.1 M sodium acetate, 0.15 M NaCl, 0.2 mg/mL
BSA, pH 5.3) and 10 μg of total protein was loaded in each well. Purified bovine
hyaluronidase (catalog number: H3506-1G, Sigma-Aldrich, MO, USA) and an HA-coated
well with only reaction buffer were used as the positive and negative control, respectively.
The 96-well plate was incubated at 37℃ for 6 hours to allow HA digestion. All wells were
washed thrice in 1xPBST.
Using hyaluronan enzyme-linked immunosorbent assay kit (catalog number: K-1200,
Echelon Biosciences Inc., UT, USA), the remainder of HA in each well detected as a
measurement of hyaluronidase activity. HA detection was carried out according to the
protocol provided by the manufacturer with modifications stated as below. 100 μL of
biotinylated HA-binding protein (catalog number: K-1203, Echelon Biosciences Inc., UT,
USA) was added to all wells and incubated at 37℃ for 1 hour. Wells were aspirated and
washed with 1xPBST three times, with excessive fluid blotted. Enzyme (catalog number:
K-1206, Echelon Biosciences Inc., UT, USA) was diluted by adding 6 mL of diluent
provided by the kit (catalog number: K-1204, Echelon Biosciences Inc., UT, USA), and
added to each well and incubated at 37℃ for 30 minutes. Wells were aspirated by blotting.
Substrate buffer (catalog number: K-1208, Echelon Biosciences Inc., UT, USA) and one
pellet of the substrate, p-nitrophenyl phosphate tablet, were mixed together and added to
each sample and incubated at room temperature for 40 minutes in the dark. Plate was
immediately read using a plate reader (Synergy H4 Hybrid Reader, BioTek, VT, USA) at
405 nm, with OD405nm inversely proportional to the HA remaining in each well after
hyaluronidase digestion.

2.9

HA size determination by agarose gel
2.9.1

HA isolation from tissue

HA extraction from tissue was conducted as described previously195,196. Briefly, 3 grams
of whole skin sample was incubated overnight at 50℃ with constant agitation in digestion
buffer (10 mM Tris-Cl, 25 mM EDTA, 100 mM NaCl, 0.5% SDS) and 20mg/mL
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proteinase K. EDTA was chelated by adding 27 mM of MgCl2, and proteinase K was
inactivated at 95℃ for 10 minutes. Nucleic acids were removed by benzonase nuclease
(500 U/μL, catalog number: E1014, Sigma-Aldrich, MO, USA) digestion at 37℃ overnight.
The absence of nucleic acid was confirmed by running samples on 1% agarose gel stained
with ethidium bromide at 100V for 40 minutes. Samples were purified through standard
phenol/chloroform protocol followed by ethanol precipitation. Briefly, samples were
mixed with 1:1 v/v phenol/chloroform, and centrifuged at 8,000xg for 15 minutes. The
aqueous phase was transferred to a new tube, with an equal volume of chloroform added
and centrifuged at 10,000xg for 15 minutes. This step was repeated twice, followed by the
addition of 2.5 volumes of ice-cold 100% ethanol to the aqueous phase. Samples were
stored at -20℃ overnight to maximize precipitation. All samples were centrifuged for 10
minutes at 14,000xg and supernatants were discarded. Pellets were washed with 4 volumes
of ice-cold 70% ethanol, and centrifuged for 10 minutes at 14,000xg. Pellets were air-dried
at room temperature, and resuspended in 20 μL of 10 mM Tris-Cl (pH 8.5). Samples were
stored at -20℃ until gel electrophoresis.

2.9.2

Gel electrophoresis and visualization

The protocol of determining HA polymer size through gel electrophoresis was adapted
from previous literature195–197. Briefly, agarose was diluted in 1xTAE buffer (40mM Tris,
20mM glacial acetate acid, 2mM EDTA, pH 8.5) and dissolved in a microwave, followed
by incubation at 45℃ for 15 minutes. Electrophoresis chambers were filled with 1xTAE
and ran at 100V for 20 minutes to clear impurities from the agarose gel. Samples were
separated into two reactions, with one reaction incubated with purified bovine
hyaluronidase (catalog number: H2506, Sigma-Aldrich, MO, USA) at 37℃ for 1 hour as
a negative control. Loading dye (0.02% bromophenol blue, 85% glycerol) was added to
both reactions. The HA polymer size in reactions was visualized on a 2.5% agarose gel,
and gel electrophoresis was carried out at 90V for 1 hour, followed by 100V for 2.5 hours.
Agarose gel was placed in staining solution (0.005% Stains-all, 50% ethanol) in the dark
overnight at room temperature, then briefly de-stained in dH2O for 20 minutes in the dark
with constant agitation. Afterward, a freshly-diluted concentrated staining solution (0.01%
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Stains-all, 50% ethanol) was incubated with the agarose gel for 40 minutes. The final destaining step was carried out in dH2O for 2 hours in the dark with constant agitation.

2.10

Statistical analyses

Experimental data are presented as mean ± standard error mean (SEM), with significances
detected at p-value < 0.05. All immunofluorescence and immunohistochemistry
experiments were performed with a sample size of n=3 animals per treatment group, 5
replicates per animal. All ELISA and RT-PCR experiments were conducted in triplicates.
Significances were calculated using two-sample t-test or one-way ANOVA, followed by
Tukey’s test as post-hoc analyses in GraphPad Prism 7 (GraphPad Software, Ca, USA,
www.graphpad.com) for quantitative analyses for immunohistochemistry.
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Chapter 3
Results

3

3.1

HA-PE application promotes epidermal HA

accumulation
To explore the potential role of HA in preventing skin tumorigenesis, HA-PE was topically
applied onto the dorsal skin of UVB-exposed Ptch+/Lacz/Hr-/- mice. HA-PE application
significantly increased total HA in the epidermis, hair follicles and the dermis (Figure 3).
This accumulation corresponded to significantly reduced hyaluronidase-2 (Hyal2) mRNA
expression, an isoform that preferentially targets surface high molecular-weight HA for
degradation. In contrast, the mRNA expression level of hyaluronidase-3 (Hyal3), a
lysosomal isoform that promotes LMW-HA cleavage into oligosaccharides, remained
unchanged (Figure 4.A). A significant decrease in total hyaluronidase activity in skin was
also observed after HA-PE application, corresponding to the increased accumulation of
epidermal HA (Figure 4.B). Since decreased hyaluronidase activity and enhanced HA
accumulation are associated with reduced tumorigenicity in murine models157,198, I next
examined sonic hedgehog signaling, which is the primary oncogenic driver underlying
BCC, in the interfollicular epidermis and hair follicles of UVB irradiated Ptch+/Lacz/Hr-/mice.
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Figure 3: Detection of HA content in the interfollicular epidermis and hair follicles of
Ptch+/LacZ/Hr-/- mice following 26 weeks of UVB exposure. A. HA-PE enhanced HA
staining intensity in epidermal keratinocytes and hair follicle cells. Insets emphasize HA
content in the hair follicles, with black arrowheads indicating HA expression on plasma
membrane. Interfollicular epidermis and associated hair follicles are separated from the
underlying dermis by the black dash line. HA content is detected using an HA-binding
biotinylated protein and detected via DAB reagent (brown), followed by counterstaining
with hematoxylin. B. Quantitative analysis of HA content detection in paraffin-embedded
tissue sections. Intensity of immunoreactivity was measured using ImageJ and threshold
against a negative control, established by omitting the HA-binding protein incubation, as a
baseline. All values represent mean and SEM for a sample size of n=3 animals per group,
with 5 replicates per animal (two-sample t test, * p<0.05).
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Figure 4: Effects of topical HA-PE administration on hyaluronidase expression and
activity. A. HYAL2 and HYAL3 mRNA expression in susceptible mice after 4 weeks of
UVB irradiation. HA-PE application significantly prevented UVB-induced HYAL2
expression. No changes in HYAL3 mRNA level were observed (n=3 animals/treatment
group, 4 replicates; two-sample t-test, * p<0.05); B. Total hyaluronidase activity of murine
skin biopsy samples after 4 weeks of irradiation, detected via an ELISA-like assay.
Statistical significance was detected via one-way ANOVA, followed by Tukey’s test (n=3
animals/treatment group, 3 replicates; ** p<0.01). For A. and B, all values are displayed
as mean ± SEM of samples.
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3.2

Suppressive effects of HA-PE on sonic hedgehog

signaling
To explore the role of epidermal HA accumulation in preventing keratinocyte tumor
initiation, activation of the oncogenic driver pathway, sonic hedgehog signaling, was
investigated in Ptch+/LacZ/Hr-/- mice. The insertion of a promoterless LacZ-neo fusion gene
replaced part of exon 1 and the entire exon 2 in Ptch1, thus producing a heterozygous lossof-function mutation and allowing β-gal to be used as a marker for sonic hedgehog
signaling, since Ptch1 gene expression is induced by the activation of this pathway186. HAPE significantly prevented β-gal overexpression in the interfollicular epidermis (IFE) and
hair follicles of UVB-exposed mice compared to both UVB- and vehicle-treated controls,
which exhibit aberrant overexpression of β-gal in IFE, sebaceous gland, the bulge region
and outer root sheath of hair follicles (Figure 5.A,B). To verify HA-PE mediated shutdown
of this oncogenic pathway in the epidermis and associated epidermal structures, I next
examined the expression pattern of GLI1, which is a hedgehog target and transcriptional
factor that is a well-characterized indicator of sonic hedgehog signaling activation. Strong
nuclear staining for GLI1 is evident in the epidermis and hair follicles of UVB- and vehicletreated controls, indicating increased expression and nuclear translocation of this
transcription factor. In comparison, HA-PE significantly restricted GLI1 expression and
nuclear accumulation in the IFE and hair follicles back to non-irradiated control levels
(Figure 6. A,B). GLI1 is minimally expressed in the ORS by both non-irradiated agematched control and HA-PE treatment group, whereas aberrant expression is observed in
all compartments of the hair follicle by UVB- and vehicle-control groups.
Given LacZ insertion in susceptible mice does not affect the protein product of the second
Ptch allele, functional tumor-suppressor at the cell membrane can still inhibit downstream
sonic hedgehog signaling. Therefore, I investigated the expression of SHH, the ligand that
binds and triggers PTCH1 endocytosis at the membrane. SHH expression was significantly
reduced post-HA-PE treatment comparing to UVB-treated, vehicle-treated and nonirradiated controls (Figure 6. C). Taken together, these findings suggest topical HA-PE
application substantially decrease inappropriate oncogenic sonic hedgehog signaling in the
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epidermis of UVB-exposed susceptible mice, possibly through the inhibition of SHH
expression. Since dysregulated hedgehog signaling often results in hyperproliferation
29,46,66

, I next investigated the proliferative responses of keratinocytes to HA-PE application.
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Figure 5: Suppressive effect of HA-PE application on UVB-induced BCC initiation
using E.coli LacZ expression as a marker in susceptible mice. A. Immuno-staining of
bacterial β-galactosidase (green) in murine skin sections counterstained with DAPI (blue).
Negative and positive controls are established using a mouse that does not express the
bacterial transgene and a tumor section from a Ptch+/LacZ:Hr-/- mouse in the vehicle control
group, respectively. HA-PE significantly prevented inappropriate expression of β-gal in
the epidermis in susceptible mice subjected to 26 of chronic UVB irradiation; B.
Quantitative analysis of β-galactosidase immuno-staining. Cells in the interfollicular
epidermis and hair follicles were quantified based on positive immunoreactivity of
bacterial β-gal through counting in QuPath. All values are displayed as mean ± SEM of
samples, and statistical significance was analyzed using two-sample t test (n=3
animals/treatment group, 5 replicates/animal; * p<0.05, ** p<0.01, *** p<0.001).
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Figure 6: HA-PE prevents oncogenic sonic hedgehog signaling in UVB-exposed
murine epidermis. A. Global prevention of inappropriate GLI1 expression and nuclear
accumulation in susceptible mice receiving 26 weeks of irradiation following HA-PE
administration. Slides are counterstained with hematoxylin and eosin (blue). Brown
staining indicates positive GLI1 expression by DAB detection. Hair follicle structure is
depicted in insets with black arrowheads indicating GLI1+ cells. B. Quantitative analysis
of GLI1 in the interfollicular epidermis and hair follicles. GLI1 expression in each
epidermal compartment was quantified by counting cells with positive GLI1
immunoreactivity in the nucleus using QuPath (n=3 animals/treatment group, 5
replicates/animals; two-sample t test, * p<0.05); C. SHH mRNA expression assessed
through RT-qPCR. Epidermal enhancement of modified HMW-HA significantly reduced
SHH expression in skin samples of susceptible mice exposed to 4 weeks of irradiation (n=3
animals/treatment group, 4 replicates/animal; two-sample t-test, * p<0.05, **** p<0.0001).
For B. and C, all values are displayed as mean ± SEM of samples.
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3.3

HA- PE restricts cell cycle progression in

susceptible mice
To elucidate the proliferative response of keratinocytes of UVB-exposed susceptible mice
to HA-PE administration, I conducted immunohistochemistry of cyclin D1 and Ki67 on
paraffin-embedded tissue sections (Figure 7, 8). Cyclin D1 is a target gene of sonic
hedgehog signaling, and is often upregulated in BCC tumors and pre-neoplastic skin lesion
following UVB irradiation199. Quantification of immunohistochemistry demonstrated a
significant reduction in cyclin D1 expression in the hair follicles by HA-PE (Figure 7.B)
compared to UVB and vehicle controls, indicating prevention of UVB-induced
proliferation. As an additional proliferation marker, Ki67 expression in hair follicles was
quantified by immunohistochemistry (Figure 8.A). No difference of Ki67 expression was
observed in the suprabasal and basal layer of the interfollicular epidermis between
irradiated control, vehicle control and HA-PE treatment192. Instead, Ki67 expression in the
hair follicle following HA-PE treatment was less than that of the UVB and vehicle controls
(Figure 8.B), especially in the bulge region, where the cancer-initiating cytokeratin-15
positive stem cells reside (Supplemental Figure 2). Further, HA-PE treatment maintained
the typical skin architecture of a distinctive stratum basale separated from suprabasal layers.
In contrast, this organized tissue architecture is absent in irradiated controls (Figure 7 A),
marked by the loss of a distinctive boundary between the stratum basale and suprabasal
layers. Together, these findings predict HA-PE restricts the oncogenic potential of UVBexposed hair follicles by inducing mitotic quiescence, possibly via regulating cyclin D1
expression to restrict G0/G1 progression. Since HA is an extracellular agent and requires
receptor binding to induce intracellular signaling, I next examined the major HA receptor
expression in UVB-exposed mice.
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Figure 7: HA-PE promotes quiescence in hair follicles. A. Immunohistochemistry of
Cyclin D1 expression in susceptible mice exposed to 26 weeks of irradiation. Slides were
counterstained with hematoxylin (blue) with cyclin D1 detected via DAB (brown). HA-PE
significantly prevented cyclin D1 overexpression in the hair follicles (black arrowheads)
comparing irradiated controls. The distinct separation between suprabasal layers and
stratum basale, a characteristic indicative of a homeostatic epidermis, is maintained by HAPE (black dashed line separating suprabasal layers and stratum basale), whereas irradiated
controls do not display clear boundaries between the basal and suprabasal layer. B.
Quantitative analyses of cyclin D1 staining in hair follicles. Cells in each epidermal
compartment positive for cyclin D1 expression were counted, and the percentage of cyclin
D1 positive cells per animal was analyzed via two-sample t test (* p<0.05, n=3
animals/treatment group, 5 replicates/animal). All values are displayed as mean ± SEM of
samples.
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Figure 8: Immunohistochemistry analysis of Ki67 expression in hair follicles of UVB
irradiated mice after HA-PE application. A. Immunohistochemistry of Ki67 (brown),
showing decreased expression in the bulge region of hair follicles after HA-PE application
in susceptible mice following 4 weeks of irradiation. Arrowhead indicates the bulge region
where adult stem cells reside. B. Quantitative analyses of Ki67 staining in hair follicles.
Ki67-positive cells in each image were counted in QuPath, and the percentages of Ki67+
cells per animal were analyzed via two-sample t test (* p<0.05, *** p<0.001, ****
p<0.0001; n=6 animals/treatment group, 5 replicates/animal). All values are displayed as
mean ± SEM of samples.
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3.4

CD44 and RHAMM expression in HA-PE treated

skin
Since HMW-HA mediates downstream signaling through interaction with cell surface
receptors, the expression of CD44 and RHAMM were examined. Immuno-staining
demonstrated upregulated expression of pan-CD44 in the epidermis and hair follicles
(Figure 9.A, B), whereas RHAMM expression was unaltered at both the protein and mRNA
level (Figure 9.B, 10.B). To determine if specific CD44 isoform expression is altered by
HA-PE administration, RT-PCR experiments were conducted using primers flanking the
variable regions to identify alternatively spliced variants of CD44 (Figure 10.A). HA-PE
administration resulted in upregulated CD44v3 isoform expression, which is characteristic
of homeostatic keratinocytes (Figure 10.A). In contrast, no differences were observed in
the CD44 standard form (CD44s, Figure 9.A) or variant isoforms (CD44v4, v8, v10) in
UVB-exposed vehicle and HA-PE treated skin (Supplemental Figure 1). To investigate the
connection between CD44, HA and prevention of sonic hedgehog signaling in susceptible
mice, the signaling pathways modulating SHH expression were examined next.
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Figure 9: CD44 and RHAMM expression in chronically UVB irradiated epidermis
following HA-PE application. A. Double immunofluorescent labelling of CD44 (red) and
RHAMM (green) in epidermis using pan-antibodies. Slides were counterstained with
DAPI shown in blue. RHAMM-/- mouse skin section stained with both CD44 and RHAMM
to establish a negative control to confirm antibody specificity. HA-PE application
enhanced CD44 expression in the epidermis of susceptible mice after 26 weeks of
irradiation, whereas RHAMM expression remains unaltered. In contrast to CD44,
RHAMM is primarily expressed in sebaceous glands and the outer root sheath of hair
follicles. B. Quantitative analysis of CD44 and RHAMM expression levels. Intensity of
immunoreactivity in the interfollicular epidermis was quantified using ImageJ. All values
are displayed as mean ± SEM of samples (n=3 animals/treatment group, 5 replicates/animal;
two-sample t test, * p<0.05).
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Figure 10: Alterations in HA receptor mRNA expression after HA-PE treatment. A.
CD44v3 expression is increased by HA-PE in susceptible mice after 4 weeks of UVB
irradiation. Black arrowheads indicate v3 expression (n=3 animals/treatment group, 3
replicates/animal. Experiment was repeated 3 times); B. mRNA expression level of
RHAMM assessed by RT-qPCR. No statistically significant differences were observed
between HA-PE and control groups (n=3 animals/treatment group, 4 replicates/animal;
two-sample t test). For A. and B, all values are displayed as mean ± SEM of samples.
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3.5

Effects of HA-PE on NF-κB signaling

Although current literature does not provide a direct connection between HMW-HA/CD44
interaction and sonic hedgehog signaling, HMW-HA/CD44 is a well-established negative
regulator of canonical NF-κB signaling121,140, which is a pathway that can induce SHH
expression to activate the oncogenic driver sonic hedgehog signaling174,175. Moreover,
mutational inactivation of Hr results in sustained inflammation driven by NF-κB signaling,
which accelerates BCC tumorigenesis in Ptch+/LacZ/Hr-/- mice186. To explore the role of NFκB signaling in relation to HA-mediated inhibition of oncogenic sonic hedgehog signaling,
nuclear localization of the p50 and p65 subunits were assessed through immunostaining
analysis of paraffin-embedded tissue sections. HA-PE significantly prevented UVBinduced nuclear localization of p50 in the interfollicular epidermis and hair follicles of
UVB-exposed mice (Figure 11). However, no difference in p65 localization was detected
between vehicle control and HA-PE-treated mice as evident by its nuclear translocation.
Since only p65 in the p65/p50 heterodimer possesses a trans-activating domain that can
promote the expression of pro-inflammatory genes200, these results indicate that HA-PE
does not suppress the canonical NF-κB pathway. Therefore, I next assessed whether HAPE suppressed UVB-induced DNA damage as a mechanism of tumor prevention.
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Figure 11: Nuclear NFκB localization in the epidermis of Ptch+/LacZ/Hr-/- mice after 4
weeks of UVB irradiation. HA-PE significantly prevented UVB-induced nuclear
localization of both subunits in the interfollicular epidermis. However, this prevention of
p65 localization was not unique to HA-PE application since vehicle control demonstrated
similar suppressive effects. Quantitative analyses of p50 and p65 nuclear localization was
conducted by counting cells exhibiting positive immunoreactivity in the nucleus. All cells
in the interfollicular epidermis and hair follicles per image were quantified in QuPath.
Statistical analysis was conducted using two-sample t test (n=3 animals/treatment group, 5
replicates/animal; * p<0.05). All values are displayed as mean ± SEM of samples.
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3.6

Keratinocytes are not protected from DNA damage

by HA-PE in susceptible mice
To investigate the potential genoprotective role of HMW-HA114–116,166–168, on keratinocytes
and adult stem cells in susceptible mice, DSBs and UVB-/ROS-signature mutations were
quantified by immunohistochemistry and ELISA assays. Interestingly, the suppression of
BCC initiation is not associated with a detectable reduction in DNA damage (Figure 12,
13). A significant increase in γ-H2AX foci formation in cells within the interfollicular
epidermis and hair follicles was associated with UVB treatments, possibly due to the
collapse of replication forks. However, a similar level of DSBs was observed in both the
vehicle control and HA-PE-treated mice (Figure 12.A,B). To assess whether differences in
ROS-induced and direct UVB-induced damage existed between the control and
experimental groups, ELISA was performed to examine 8-oxo-dG and CPD formations in
susceptible mice (Figure 13. A, B). Again, no significant differences in UVB- and ROSinduced DNA damage were detected between the irradiated vehicle control and HA-PEtreated group. Vertical lineage tracing of proliferating progenitor cells originating from the
stratum basale was used as a preliminary method to assess DSB repair activity in the
epidermis. However, these analyses demonstrated no significant differences between all
experimental groups (Figure 12. C). predicting similar repair activities between control and
experimental groups are similar. Collectively, these findings demonstrate that the mice
receiving HA-PE treatment exhibit a similar DNA damage load in IFE and hair follicles as
the UVB- and vehicle-treated controls, and that differences in DNA damage, and
potentially mutational load, do not account for HA-PE suppression of BCC. Since the
accumulation of DNA damage may overwhelm the repair machinery and trigger
programmed cell death, I next examined apoptosis as a potential mechanism in the removal
of these harmful cells.
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Figure 12: HA-PE does not alter the double-stranded breaks in the epidermis of
susceptible mice after 4 weeks of UVB irradiation. A. Immunohistochemistry of γH2AX in paraffin-embedded tissue counterstained with hematoxylin (blue). Brown
staining is indicative of γ-H2AX foci formation. B. Quantitative analysis of γ-H2AX foci,
a marker for double-stranded DNA breaks, in the epidermis and hair follicles. Cells in the
interfollicular epidermis with strong γ-H2AX immunoreactivity were quantified, and the
percentage of γ-H2AX positive cells in each epidermal compartments were analyzed for
statistical significance. However, foci formation is not significantly different between
control and treatment groups; C. Vertical lineage tracing of damage-sustaining progenitor
cells and γ-H2AX+ daughter cells in the interfollicular epidermis. The percentage of
daughter cells positive for γ-H2AX foci within a lineage was quantified thorough QuPath
by counting. For B, and C, two-sample t test was conducted to assess statistical significance
(* p<0.05; n=3 animals/treatment group, 5 replicates/animal). All values are displayed as
mean ± SEM of samples.
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Figure 13: ROS- and UVB-induced DNA damages are not altered by HA-PE
application following 4 weeks of irradiation. ROS/UVB-induced DNA damages are
measured by the ROS-adduct 8-oxo-dG and cyclobutane pyrimidine dimer (CPD)
formation in extracted DNA, respectively. No statistically significant difference in DNA
damages are observed between irradiated, vehicle-treated controls, and HA-PE treated
group. Statistical analysis was conducted by two-sample t test, experiments were repeated
3 times (* p<0.05, ** p<0.01; n=3 animals/treatment group, 5 replicates/animal). All values
are displayed as mean ± SEM of samples.
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3.7

HA-PE application promotes selective apoptosis in

hair follicles
BCL2 is a pro-survival protein and a target gene that is upregulated by sonic hedgehog
signaling in BCC tumorigenesis, and is often over-expressed to facilitate cancer cell
survival by preventing cytochrome c release from the mitochondria201,202. To elucidate
whether apoptosis contributes to HMW-HA-mediated resistance against BCC initiation, I
first quantified BCL2 expression in the epidermis and hair follicles of susceptible mice.
Expression of epidermal and follicular BCL2 was suppressed following HA-PE application
in UVB-irradiated mice, whereas UVB- and vehicle-treated controls exhibited an elevation
of this pro-survival protein in the epidermis and hair follicles (Figure 14). BCL2 is an
early participant in the apoptosis cascade202. To verify these results and to establish
whether keratinocyte apoptosis is altered by HA-PE, TUNEL assay, which marks late-stage
apoptosis, was quantified. Interestingly, HA-PE promotes apoptosis in cell subsets within
the outer root sheath and bulge of hair follicles, where the K15+ stem cells that are known
to be cancer-initiating in the Ptch+/LacZ mouse model reside (Supplemental Figure 2)58,60–62.
Apoptosis in these hair follicle regions was uniquely observed in HA-PE treatment,
whereas control groups only exhibited apoptosis of suprabasal keratinocytes near the
stratum corneum that is typical of normal keratinocyte turnover (Figure 15).
To further identify the nature of these hair follicle stem cells, I double-labeled paraffinembedded tissue sections with a marker for BuSCs, K15, together with a marker for
apoptosis, caspase 3. Immunofluorescent co-localization analyses demonstrated that 40%
of total K15+ cells in the hair follicles are apoptotic, as indicated by positive caspase 3
expression at week 26 of irradiation (Figure 16.A,B). Consistent with these data, K15+ cells
were continuously lost between week 6 and 26 following HA-PE administration, while the
number of K15+ cells in non-irradiated, UVB-exposed and vehicle controls remained
constant (Figure 16.C). Given K15 is a well-established marker of BuSCs 61,203,204 that can
give rise to BCC58,60,62, these data suggest HA-PE promotes the removal of these K15+
stem cell via apoptosis as a mechanism of cancer prevention. To verify K15+ cells are the
cancer-initiating cells in this model, I next investigated the origin of tumors through
examining the histopathology of identified BCCs in Ptch+/LacZ/Hr-/- mice.
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Figure 14: HA-PE reduces pro-survival BCL2 expression in the interfollicular
epidermis and hair follicles of susceptible mice after 26 weeks of UVB irradiation. A.
Immunohistochemistry of BCL2 detected via DAB (brown). Black arrowheads indicate
BCL2+ cells in the bulge of hair follicles; B. Quantitative analyses of BCL2 expression in
the epidermis and hair follicles. Percentage of cells positive for BCL2 immunoreactivity in
the interfollicular epidermis and hair follicles was quantified via counting in QuPath. All
values are displayed as mean ± SEM of samples, and analyzed using two-sampled t test (*
p<0.05, ** p<0.01; n=3 animals/treatment group, 5 replicates/animal).
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Figure 15: HA-PE enhances apoptosis in the outer root sheath and bulge region of
hair follicles of mice following 26 weeks of irradiation. A. TUNEL analysis of paraffinembedded tissue. Apoptotic cells are labeled in green and counterstained with DAPI (blue).
White arrowheads indicate apoptotic cells in hair follicles; B. Quantitative analysis of
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apoptotic cells in the hair follicle. Five images were taken per sample, and the percentage
of apoptotic cells in was quantified through counting cells with green fluorescence per
image. All values are displayed as mean ± SEM of samples. Two-sample t test was
conducted to assess significance (* p<0.05, n=3 animals/treatment group, 5
replicates/animal).
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Figure 16: HA-PE enhances apoptosis in K15+ adult stem cells in hair follicles of UVBirradiated susceptible mice. A. Double-labeled immunofluorescent analysis of K15 (red)
and caspase 3 (green), counterstained with DAPI (blue). White arrowheads indicate colocalization of K15 and caspase 3 in hair follicles of Ptch+/LacZ/Hr-/- mice after 26 weeks of
irradiation; B. Quantitative analyses of immunofluorescent staining. All K15 cells positive
for caspase 3 staining in hair follicles were counted, and analyzed via two-sample t test (*
p<0.05; n=3 animals/treatment group, 5 replicates/animal); C. Number of K15+ cells in
hair follicles of susceptible mice after 4 and 26 weeks of irradiation. Cells displaying
positive immunoreactivity for K15 in each image were counted (approximately 500 cells
per image) and analyzed via two-sample t test (* p<0.05, *** p<0.001; n=3
animals/treatment group, 5 replicates/animal). For B. and C, all values are displayed as
mean ± SEM of samples.
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3.8

Immunohistochemical analysis of UVB-induced

BCC tumors in Ptch+/LacZ/Hr-/- mice
To elucidate the epidermal compartment and verify the cancer-initiating cell of BCC
tumorigenesis in our mouse model, I examined the histopathology of paraffin-embedded
macroscopic tumor sections from the two control groups as described previously58,62. BCC
tumors driven by Ptch1 loss are characterized by a radiating, branching organization
reminiscent of hair follicle differentiation in this model. These micronodular tumors
displayed scarce stroma and sparse blood vessels, with cells organized into irregularly
shaped nests. In certain portions of the tumor, elongated or spindle-like cells with a
minimal degree of nuclear palisading were observed (Figure 17.A, inset), while a
prominent cleavage was present between surrounding connective tissue and tumor stroma
(Figure 17. A). Interestingly, BCCs originating from the follicles often display
inappropriate myoepithelial differentiation, as seen in sporadic human BCC and
susceptible mouse models62,205,206. Since smooth muscle actin (SMA) is a well-established
marker for myoepithelial differentiation, I therefore conducted immunohistochemistry to
examine SMA expression in macroscopic BCC tumors. Strong intracytoplasmic SMA
immunoreactivity is detected in BCCs and hair follicles of UVB-exposed tumor-adjacent
skin, but was absent in the stratum basale and suprabasal layers of Ptch+/LacZ/Hr-/- mice
(Figure 17.B,C). Interestingly, a direct association between these keratinocyte tumors and
hair follicles was often observed. Rare initial phases of this keratinocyte tumor originating
from the bulge region (Figure 17.D) and ORS (Figure 17. D, inset) of hair follicles were
detected in irradiated Ptch+/LacZ mice, with strong K15 immunoreactivity in peripheral cells.
Similarly, K15 expression was also detected in the peripheral cells of tumor nests in
macroscopic BCCs identified as BCC by pathologists (Figure 17.E). Together, these data
suggest that the UVB-induced BCCs in Ptch+/LacZ/Hr-/- mice are associated with the hair
follicles, and likely originate from the K15+ adult stem cells that are present in the bulge
and ORS regions.
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Figure 17: Immunohistochemistry analyses of UVB-induced BCC tumors. A. UVBinduced BCCs in Ptch+/LacZ/Hr-/- mice are characterized by irregularly shaped nests
organized in a radiating pattern, with scarce stroma and blood vessels. Insets and
arrowheads show elongated cells in small, irregular nests with minimal nuclear palisading.
B. Expression pattern of smooth muscle actin (SMA) in macroscopic BCC tumors. SMA
was present in both the tumor stroma and the cytoplasm of tumor cells. C. Strong SMA
expression detected in the tumor-adjacent hair follicle of UVB-exposed vehicle control.
No SMA immunoreactivity was observed in stratum basale or suprabasal epidermis. D.
BCC tumors in Ptch+/LacZ/Hr-/- mice are directly associated with the hair follicles. Rare
initial stages of BCC exhibit atypical outgrowth arising from the approximate region of the
bulge (white arrowhead) or outer root layer sheath (inset) that are focally-positive for K15
expression (red). E. K15 expression (red) in macroscopic BCCs. Similar to K15 expression
in the atypical outgrowth originating from hair follicles, peripheral cells in macroscopic
BCC are strongly positive for K15 immunoreactivity.
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Chapter 4

4

Discussion
4.1

HA-PE phenocopies the cancer-resistant naked

mole-rat to prevent carcinogenesis in susceptible mice
Once thought to be an inert component of the ECM, HA is now recognized as a dynamic
molecule that facilitates extracellular protein-protein interaction and intracellular
signaling106,131,146. The loss of native HA in epidermis is characteristic in aging,
inflammation, chronic UV exposure, and tumorigenesis106,107,118. Previous studies report
HMW-HA accumulation elicits suppressive effects on murine astrocytoma and colon
carcinoma xenograft tumor growth

169,170

. Further, HMW-HA arrests breast cancer cell

growth in vitro and spheroid growth, marked by downregulated cyclin D1 and PCNA
expression95,176 To our knowledge, this is the first study to examine the effects of epidermal
HMW-HA enhancement on keratinocyte carcinoma initiation. I demonstrated hyaluronanphosphatidylethanolamine polymers (HA-PE) significantly increase large HA polymer
content in the epidermis (Figure 3). HA-PE application suppresses hyaluronidase activity
and HYAL2 expression (Figure 4), an extracellular hyaluronidase that degrades native HA,
predicting the accumulated epidermal HA is the high molecular-weight species. Moreover,
the topical application of HA-PE prevented UVB-induced histologically-detectable BCC
tumor initiation as detected by histology and inhibition of and significantly blocked Ptch1
promoter expression in susceptible mice (Figure 5).
Previous in vivo and cell studies demonstrate sonic hedgehog hyperactivation drives BCC
tumorigenesis28,29,33,207, and its inhibition leads to reduced proliferative capacity and tumor
growth208,209. Specifically, animal studies suggest sonic hedgehog signaling driven by lossof-function mutation in Ptch1 directly causes BCC originating from the bulge58,60,62, but an
IFE with hyperactive sonic hedgehog signaling may also constitutive a permissive
microenvironment for BCC initiation58,59,61. Moreover, HA is a recognized agent in
mediating maintenance and support of stem-cell niches, including the bulge within hair
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follicles210. In association with HA accumulation, we show that β-gal staining measuring
Ptch1 promoter expression is significantly reduced in the IFE and hair follicles (Figure 5),
indicating suppression of sonic hedgehog signaling in UVB-exposed Ptch1+/- mice. The
expression and nuclear translocation of the transcriptional factor GLI1, another wellestablished marker for sonic hedgehog activation, is similarly suppressed by HA-PE in IFE
and follicles (Figure 6.A,B). Decrease in sonic hedgehog signaling is further verified by
assessing target gene CNND1 (Figure 7) and BCL2 (Figure 14) expression, which were
significantly diminished in susceptible mice after HA-PE application. Interestingly, HAPE reduced the activating ligand SHH expression (Figure 6.C), suggesting a mechanism of
suppressing the hedgehog pathway. Taken together, our data predict HA-PE prevents
UVB-induced BCC by inhibiting aberrant sonic hedgehog signaling in two epidermal
compartments: the hair follicle bulge, and the IFE. HA-PE targets SCs in the bulge via
restricting sonic hedgehog signaling to a level similarly observed in non-irradiated controls,
and limits the tumorigenic potential of stem cells in stratum basale via preventing sonic
hedgehog signaling in IFE.
This prevention of tumorigenicity was associated with restricted cyclin D1 and Ki67
expression in the hair follicles of susceptible mice (Figure 7, 8). CCND1, a target gene of
sonic hedgehog signaling and mediator of G1-S progression, was significantly restricted
but not extinguished in the hair follicles (Figure 7), thus further verifying decreased sonic
hedgehog signaling following HA-PE application. Similarly, Ki67 expression was also
significantly reduced by HA-PE application in the bulge region of hair follicles, where the
adult stem cells reside (Figure 8). Together, these data predict HA-PE promotes mitotic
quiescence in UVB-irradiated hair follicles to limit their oncogenic potential.
In naked mole-rats, large HA polymers are also protected from degradation by reduced
extracellular hyaluronidase activities94. HMW-HA accumulation confers cancer resistance
in this species via promoting contact inhibition hypersensitivity through inducing cyclindependent kinase inhibitor p16INK4A/B expression94, 95, thereby promoting quiescence in
vitro as reflected by the decreased PCNA expression95. The effects of HA-PE reported here
therefore phenocopy the properties of HMW-HA in the long-lived rodent naked-mole rat
by increasing HA polymer accumulation, downregulating hyaluronidase activity, inducing
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relative mitotic quiescence, and exerting an anti-tumorigenic effect. However, the protein
isoform (p16INK4A/B) responsible for ECI in naked mole-rats is not expressed in mice93,94.
Thus, further examinations of mammalian contact inhibition pathways (i,e: Hippo/YAP)
may shed new lights on the involvement of contact inhibition in the prevention of
keratinocyte carcinogenesis. Moreover, HA-PE elicited apoptotic responses in the known
cancer-initiating subpopulation of adult stem cells in this susceptible model, whereas
HMW-HA produced by H. glaber was reported to induce apoptosis in breast cancer cells
non-specifically95. To my knowledge, the effects of H. glaber HMW-HA on cancer stem
cells have not been investigated. Here, the promotion of mitotic quiescence and apoptosis
appear to be linked to an effect of HA-PE on sonic hedgehog signaling, as cyclin D1 and
BCL2 are target genes of this oncogenic signaling pathway.
To begin to identify the mechanisms behind HA-PE block in hedgehog signaling and BCC
initiation, I examined the expression of the major HA receptors in keratinocyte. CD44 is
the major keratinocyte HA receptor133,135 and is a promising target in facilitating the tumor
suppressive effect of HA-PE because CD44 mediates the cancer resistance of HMW-HA
in naked mole-rats

94,95

. Moreover, CD44 is essential for several HMW-HA-mediated

suppression of proliferation126,138, tumor growth126,169,170, and invasion125,157. Keratinocytes
in homeostatic epidermis primarily express CD44v3-v10, with v3 being the most
prominent isoform135. Here, we report that HA-PE increased CD44 protein expression in
the epidermis and hair follicles (Figure 9) and maintained CD44v3 isoform expression,
which is characteristic of homeostatic keratinocytes (Figure 10.A) that was lost in UVB
exposed controls. In addition, immunohistochemistry demonstrated that the interfollicular
epidermis of HA-PE treated mice retained a distinct stratum basale and organized
suprabasal layers following UVB exposure. In contrast, this tissue architecture indicative
of a homeostatic epidermis was lost in irradiated controls, as the stratum basale cannot be
distinguished from suprabasal layers in the epidermis (Figure 7.A). Taken together, the
findings here predict epidermal HA maintains homeostasis in the interfollicular epidermis
via promoting CD44v3 isoform expression and maintaining the appropriate epidermal
architecture. Since CD44 is the primary receptor that is responsible for the HA-mediated
cancer resistance in naked mole-rats93,94, it is possible that HA-PE exerts its antitumorigenic effects through interaction with CD44 in the epidermis and hair follicles.
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HA-PE mediated suppression is not orchestrated

4.2

through canonical NF-κB signaling
A direct effect of CD44 on sonic hedgehog pathway activity has not been previously
reported to my knowledge. However, HMW-HA/CD44 signaling is a well-established
inhibitor of canonical NFκB signaling, a pro-inflammatory pathway that promotes SHH
expression and activation of sonic hedgehog signaling174,175. Previous studies report
canonical NFκB signaling, activated by the p65/p50 heterodimer, is essential for skin
carcinogenesis in mice75,186. For example, the p65 inhibitor SSZ significantly reduces the
nuclear translocation of canonical NFκB and UVB-induced BCC tumor load in
Ptch+/LacZ/Hr-/- mice, although SSZ does not completely prevent tumor initiation in these
susceptible mice186. Unexpectedly, HA-PE did not alter p65 nuclear translocation (Figure
11), possibly due to altered receptor clustering at the membrane. Since canonical NFκB
signaling requires the dimerization and translocation of p65/p50 subunits, the lack of
difference in p65 translocation suggests that canonical NFκB signaling was not
significantly affected by HA-PE treatment. In contrast, p50 nuclear translocation in
susceptible mice was significantly prevented by HA-PE application relative to UVBexposed vehicle control (Figure 11), predicting suppression of the non-canonical NFκB
pathway. Nuclear p50 homodimer accumulation and constitutive kappaB-binding
mediated by non-canonical signaling are characteristic of skin neoplasms in mice 211,212. In
Ptch+/LacZ/Hr-/- mice, non-canonical NFκB signaling is reported to accelerate tumor growth
by creating a pro-inflammatory microenvironment, and augment BCC pathogenesis
through upregulating the activating ligand SHH expression to sustain sonic hedgehog
signaling

212

. It is well-established that the p50 subunit does not contain a trans-activating

domain. Therefore, an additional trans-activator, such as BCL3, is required to for p50
homodimer to acquire transcriptional activity212,213. BCL3 overexpression is associated
with stabilization of the p50 homodimer in squamous cell carcinoma211, and enhanced
BCL3 activity is associated pathogenesis of various neoplasms214,215. Moreover, BCL3
knockdown significantly reduces PTCH1, GLI1 and GLI2 expression in murine BCC cells,
thus predicting crosstalk between the two pathways212. In this context, HA-PE may
suppress sonic hedgehog signaling by preventing non-canonical NFκB-induced SHH
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expression212. Future experiments should be conducted to investigate the role of HMWHA, CD44 and possibly other HA receptors (i.e: Toll-like receptors) in modulating the
non-canonical NFκB pathway in the context of BCC tumorigenesis, and further examine
the relationship between p50 homodimers and sonic hedgehog signaling.

4.3

HA-PE promotes apoptosis of DNA-damaged

K15+ cancer-initiating stem cells in hair follicles
UVB is a well-documented environmental carcinogen that threatens genome integrity via
directly inflicting structural alterations in DNA, such as promoting dimer formation also
add ROS damage, which is not a direct effect. Mice and humans employ various strategies
to ensure genome integrity against UVB insults, such as the production of UV-absorbing
pigments, expression of anti-oxidants, and repair mechanisms including base and
nucleotide excision repair

67,68,76

. However, these mechanisms do not completely protect

DNA from UV, and damage accumulation is regarded as the primary skin carcinogen 69,71.
Previous studies have characterized HMW-HA as a genoprotective agent by its ability to
scavenge epidermal ROS. For example, HMW-HA reduced γ-H2AX foci formation,
intracellular ROS levels, and damage-induced apoptosis of human corneal and alveolar
epithelial cells

114,171,172

. It is therefore surprising that HA-PE-mediated suppression of

BCC is not associated with reduced DNA damage in UVB-exposed mice (Figure 12, 13).
No significant differences were observed in γ-H2AX foci formation, nuclear DNAassociated ROS adduct 8-oxo-DG, and UVB-induced CPD in UVB controls and HA-PE
treated epidermis and hair follicles. As a preliminary assessment of DSB repair in the
epidermis, I performed a vertical lineage tracing of proliferating γ-H2AX+ progenitor cells
in the stratum basale and associated γ-H2AX+ daughter cells (Figure 12. C). The number
of γ-H2AX-positive daughter cells that originated from the same basal stem cell served as
a reflection of DSB escaping DNA repair in the epidermis. The number of γ-H2AX+
progenies in the suprabasal layers was not significantly different between experimental
groups, suggesting the efficiency of DSB repair was not significantly altered by HA-PE
application in the epidermis. Although my findings do not support previous reports of the
genoprotective function of HA, they are consistent with previous studies showing that
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UVB-exposed eyelid keratinocytes sustain a high level of DNA damage but do not undergo
neoplastic transformation79–83. Deep next-generation sequencing shows a prevalent and
high mutational load in oncogenic driver mutations of phenotypically-normal skin without
detectable tumor development, suggesting that an innate barrier exist that restricts the
carcinogenic potential of driver mutations79,83,86.
Although the precise downstream mechanism remains unclear, apoptosis is a wellestablished mechanism of preventing carcinogenesis. Apoptosis is triggered when DNA
damage accumulation overwhelms the repair machinery, or by blocking signaling of
pathways that normal or tumor cells rely upon for proliferation, survival, and renewal. In
UVB-exposed Ptch+/LacZ/Hr-/- mice, HA-PE restricts proliferation (as detected by
decreased Ki67 expression, Figure 8) and promoted apoptosis cell subsets in the ORS and
bulge of hair follicles, which were uniquely observed in HA-PE treated groups (Figure 15).
In human and mouse, the ORS and bulge regions contain slow-cycling K15-expressing
stem cells, which can migrate into the stratum basale to transiently participate in wound
healing upon stimulated by sonic hedgehog signaling. In Ptch+/- mice, K15+ cells and their
progenies have the potential to give rise to BCC after chronic UVB exposure. Here, doublelabelling immunofluorescence demonstrated these apoptotic subsets in the hair follicles
were K15-positive (Figure 16). Intriguingly, apoptotic K15+ cells were not observed in the
stratum basale following HA-PE treatment (Figure 16. A), possibly due to the lack of
migration into the interfollicular epidermis (Supplemental Figure 2.B). HA-PE suppression
of sonic hedgehog signal in the microenvironment may prevent K15+ stem cell migration
into the IFE, since paracrine sonic hedgehog signal from the dermis and innervated neurons
are required to initiate this process. Moreover, approximately 40% of total K15+ adult stem
cells were apoptotic after 26 weeks of irradiation and HA-PE application. Consistent with
this finding, the number of K15+ cells in UVB-irradiated HA-PE-treated mice was similar
to controls at 4 weeks, but reduced significantly after 26 weeks of irradiation (Figure 16,
C). This finding indicates that the adult stem cells were gradually lost due to cell death over
26 weeks. This apoptosis was associated with suppression of the pro-survival BCL2
expression in the epidermis and hair follicles (Figure 14). Evasion of apoptosis and
sustained BCL2 expression are a hallmark of BCC carcinogenesis199,201,216, all of which
were absent in HA-PE treated group.

67

Previous studies report that the cell of origin in BCC pathogenesis depends on the
component of sonic hedgehog signaling that is affected. For example, mutational
inactivation of PTCH1 gives rise to BCCs originating from the K15+ BuSCs in the hair
follicles. In contrast, constitutive activation of SMO or GLI2 produce BCCs arising from
the K14+ adult stem cells in the interfollicular epidermis. Interestingly, BCCs arising from
different epidermal compartments exhibit unique histopathological characteristics, which
can be used to provide clues of the cell of origin when studying these keratinocyte tumors.
Therefore, to investigate the epidermal compartment and the identity of cancer-initiating
cells, I examined the histopathological characteristics of macroscopic BCC tumors as
described previously58,62. The BCC tumors in Ptch+/LacZ/Hr-/- mice displayed irregularly
shaped nests organized in a radiating, branching pattern resembling follicular
differentiation (Figure 17.A), consistent with previous reports of micronodular BCC
arising from hair follicles56,58,59. Further, smooth muscle actin (SMA) expression in hair
follicle cells is suggestive of inappropriate myoepithelial differentiation, a prominent
feature in sporadic BCC patients and susceptible mice driven by sonic hedgehog activation
under the K15 promoter58. Interestingly, strong intracytoplasmic SMA reactivity was
observed in BCC tumors (Figure 17.B) and the tumor-adjacent hair follicles (Figure 17. C),
but was absent from the tumor-adjacent interfollicular epidermis, thus predicting a
connection between BCCs in Ptch+/LacZ/Hr-/- mice and hair follicles. Further, rare initial
phases of neoplasm development demonstrated a direct association with the hair follicles
(Figure 17.D). Strong K15 expression was detected in peripheral cells of developed tumor
nests (Figure 17.E) and at early stages of atypical outgrowth from the bulge (Figure 17.C),
thus predictive of BCCs arising from the hair follicles. This is supported by previous
studies reporting prominent K15 immunoreactivity in human nodular BCCs, a subtype
commonly associated with the bulge204,217. Taken together, the findings here predict the
macroscopic BCC tumors likely arise from the K15-expressing stem cells in hair follicles
in Ptch+/LacZ/Hr-/- mice.
Since cancer-initiating cells rely on sonic hedgehog signaling to drive BCC tumorigenesis,
the loss of the oncogenic driver triggers apoptosis in pre-malignant cells. Previous in vivo
and cell culture studies show the depletion of sonic hedgehog by an inhibitor (cyclopamine)
leads to adult stem cell quiescence and apoptosis46,47. In this study, sonic hedgehog
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signaling in the bulge and ORS was reduced by HA-PE application, which coincided with
enhanced apoptosis in K15+ adult stem cells that rely on sonic hedgehog hyperactivation
for tumorigenesis. Further, the data in this study demonstrated the activating ligand mRNA
expression, SHH, was inhibited by HA-PE application (Figure 6.C), suggesting signaling
inhibition occurs at the PTCH receptor level. In this context, CD44 is a promising candidate
of signal transduction mediated by HA binding. CD44 is a well-established HA receptor
that regulates downstream pathways, such as Wnt/beta-catenin218,219, that modulate SHH
transcription220–222. Further, signaling downstream of CD44 is dependent on the identity of
CD44 variant132,134,223, thus adding an additional layer of complexity. Therefore, future
experiments should be conducted to elucidate the mechanism underlying HMW-HAmediated inhibition of sonic hedgehog activation and the role of CD44.

4.4

Future directions

Causation of HA-PE application and sonic hedgehog suppression should be established in
future experiments. K15+ cells isolated from Ptch+/- mice will be irradiated and treated with
HA-PE. It is expected that HA-PE will reduce sonic hedgehog activation, restrict
proliferation, and promote apoptosis. Since HA-PE reduced SHH transcription, an
activating ligand that is not a hedgehog target gene, we speculate that pathway inhibition
occurs at the Shh/PTCH1 level. Therefore, the addition of a downstream activator, such as
an SMO agonist, is expected to override the effects of HA-PE in K15+ cells. Further, we
speculate that this HA suppression of BCC initiation is orchestrated by CD44 in the hair
follicles. To that end, CD44 standard- and variant-specific antibodies that interfere with
HA-binding should be added to the Ptch1+/- K15+ cells as additional controls, and examined
to assess whether HA-mediated suppression is conducted through CD44 binding. It is
expected that interference with CD44/HA interaction will abolish the suppressive effect of
HA-PE on sonic hedgehog signaling and proliferation. Since dysregulated proliferation,
survival and inappropriate differentiation of damage-sustaining cells in hair follicles were
detected in this study, mutational analyses should also be conducted on skin biopsies to
examine alterations in additional driver pathways that regulate proliferation, stem cell
survival and differentiation, such as WNT/β-catenin and Notch signaling, in the skin.
Moreover, mutational analyses will provide data on the identity of the somatic mutations
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in UVB-exposed susceptible mice, thus allowing us to examine whether HA-PE modifies
the microenvironment to select for mutations to prevent carcinogenesis. Lastly, RNAseq
analyses should be performed to provide an unbiased assessment of transcriptome and
pathway alterations induced by HA-PE application.
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5

Conclusions

Taken together, the data presented here suggest a novel mechanism of HA-mediated
resistance against tumor initiation in the context of BCC carcinogenesis. The accumulation
of HMW-HA in epidermis did not exert its protective functions through shielding
epidermal cells from DNA damage. Instead, HA-PE inhibited the tumorigenic potential of
mutations via restricting proliferation and promoting apoptosis. Specifically, HA-PE
prevents oncogenic sonic hedgehog signaling in the hair follicles, where the K15+ cancerinitiating cells reside in the Ptch+/LacZ/Hr-/- model. This chronic loss of oncogenic driver
signaling limited the proliferative capacity of K15+ BuSCs, and resulted in a gradual
depletion of cancer-initiating cells via apoptosis. However, this reduction in proliferation
and enhanced apoptosis did not interfere with homeostasis as indicated by CD44v3
expression. HA-PE also contributed to establishing proper tissue architecture by
maintaining a distinctive stratum basale separated from suprabasal layers. Overall, the
findings here implicate HA-PE as a promising BCC prophylactic that can reduce BCCassociated healthcare costs and improve quality of life in patients. Moreover, aberrant
hedgehog signaling is implicated in cancer stem cell maintenance224,225,226 that is required
for tumor initiation in the breast, prostate and colon cancer38,227,228. Therefore, a
mechanistic understanding of HA-PE mediated resistance will have broad applications for
developing preventative therapies. HA-PE may be re-purposed to reduce the tumorigenic
potential of at-risk patients, and permit the development of preventative medicines against
breast, prostate, and colon cancer 38,226,227,228.
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Appendix A: Supplemental materials

Supplemental Figure 1. HA-PE on CD44 isoform expression. mRNA expression of
CD44s, v4, v8, v10 were assessed through RT-PCR using primers flanking the variable
region in CD44, and compared with the housekeeping gene GAPDH. Isoform expression
of CD44v4, v8, v10 were unchanged by HA-PE application in susceptible mice after 4
weeks of UVB irradiation. Experiments described in A. and B. were repeated three times.
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Supplemental Figure 2. K15-expressing bulge stem cells are not lost in disrupted hair
follicles in Ptch+/LacZ/Hr-/- mice after 4 weeks of irradiation. A. K15 expression (red) in
hair follicles, and; B. in stratum basale of control and treatment groups. All slides
counterstained with DAPI (blue). In normal follicles, the outer root sheath extends past the
bulge region into the hair bulb, and the bulge region is located above the sebaceous gland.
The hair bulb disintegrates after the first hair cycle in Hr-/- mice, and the bulge region is
often located at the bottom of the disrupted hair follicle. However, these K15+ stem cells
are not lost despite the disrupted morphology. Further, K15+ stem cells can migrate into
stratum basale to participate in interfollicular epidermis renewal. However, no K15+ cells
in stratum basale were observed in HA-PE treated group. Histology sections of wildtype
epidermis are adapted from Blue Histology, University of Western Australia
(http://www.lab.anhb.uwa.edu.au/mb140/). Arrowheads indicate the outer root sheath
(ORS) and bulge region in disrupted and wildtype hair follicles.
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